PRKD2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| O00488 | S93 | Sugiyama | ZNF593 ZT86 | STNLKTHFRSKDHKKRLKQLsVEPysQEEAERAAGMGSYVP |
| O14745 | S290 | Sugiyama | NHERF1 NHERF SLC9A3R1 | REALAEAALEsPRPALVRsAssDtsEELNsQDsPPKQDSTA |
| O14745 | S291 | Sugiyama | NHERF1 NHERF SLC9A3R1 | EALAEAALEsPRPALVRsAssDtsEELNsQDsPPKQDSTAP |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14974 | S995 | Sugiyama | PPP1R12A MBS MYPT1 | ADRSLLEMEKRERRALERRIsEMEEELKMLPDLKADNQRLK |
| O15143 | S310 | Sugiyama | ARPC1B ARC41 | QSSQRGLTARERFQNLDKKAssEGGtAAGAGLDsLHKNsVs |
| O43175 | S166 | Sugiyama | PHGDH PGDH3 | KtLGILGLGRIGREVATRMQsFGMKTIGYDPIISPEVSASF |
| O43615 | S180 | Sugiyama | TIMM44 MIMT44 TIM44 | AESVSKGGEKLGRTAAFRALsQGVEsVKKEIDDsVLGQtGP |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O60664 | S148 | Sugiyama | PLIN3 M6PRBP1 TIP47 | KVsGAQEMVssAKDTVAtQLsEAVDATRGAVQSGVDKTKsV |
| O60749 | S226 | Sugiyama | SNX2 TRG9 | PPAPEKSIVGMTKVKVGKEDssSTEFVEKRRAALERYLQRT |
| O75369 | S2532 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | ASKVTSKGAGLSKAFVGQKssFLVDCSKAGSNMLLIGVHGP |
| O76021 | S314 | Sugiyama | RSL1D1 CATX11 CSIG PBK1 L12 | RNFEKQKERKKKRQQARKtAsVLsKDDVAPEsGDtTVKKPE |
| O95155 | S105 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | LsssPsNsLEtQsQsLsRsQsMDIDGVSCEKsMsQVDVDsG |
| O96013 | S99 | PSP | PAK4 KIAA1142 | DGALTLLLDEFENMSVTRsNsLRRDsPPPPARARQENGMPE |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00558 | S175 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | SKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKELN |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04792 | S82 | GPS6|Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07237 | S427 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | WDKLGEtyKDHENIVIAKMDstANEVEAVKVHsFPtLKFFP |
| P07237 | T428 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | DKLGEtyKDHENIVIAKMDstANEVEAVKVHsFPtLKFFPA |
| P07339 | S37 | Sugiyama | CTSD CPSD | PASALVRIPLHKFTSIRRtMsEVGGsVEDLIAKGPVSKYSQ |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P10412 | S36 | Sugiyama | H1-4 H1F4 HIST1H1E | EKtPVKKKARKsAGAAKRKAsGPPVsELItKAVAASKERsG |
| P10412 | S89 | Sugiyama | H1-4 H1F4 HIST1H1E | AGyDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P10412 | T92 | Sugiyama | H1-4 H1F4 HIST1H1E | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P11532 | S3623 | Sugiyama | DMD | EAKVNGttVssPstsLQRsDssQPMLLRVVGSQTSDSMGEE |
| P12277 | S164 | Sugiyama | CKB CKBB | PHCsRGERRAIEKLAVEALssLDGDLAGRyyALKsMtEAEQ |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | S515 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQ |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15374 | S128 | Sugiyama | UCHL3 | KDKMHFESGSTLKKFLEEsVsMsPEERARyLENyDAIRVtH |
| P15880 | S281 | Sugiyama | RPS2 RPS4 | FtKsPyQEFtDHLVKtHtRVsVQRtQAPAVATt________ |
| P15880 | T278 | Sugiyama | RPS2 RPS4 | EtVFtKsPyQEFtDHLVKtHtRVsVQRtQAPAVATt_____ |
| P15880 | T285 | Sugiyama | RPS2 RPS4 | PyQEFtDHLVKtHtRVsVQRtQAPAVATt____________ |
| P16401 | S92 | Sugiyama | H1-5 H1F5 HIST1H1B | GGYDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P16401 | T95 | Sugiyama | H1-5 H1F5 HIST1H1B | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16402 | S37 | Sugiyama | H1-3 H1F3 HIST1H1D | KtPVKKKAKKAGATAGKRKAsGPPVsELItKAVAASKERsG |
| P16402 | S90 | Sugiyama | H1-3 H1F3 HIST1H1D | AGyDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P16402 | T93 | Sugiyama | H1-3 H1F3 HIST1H1D | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16403 | S36 | Sugiyama | H1-2 H1F2 HIST1H1C | EKAPVKKKAAKKAGGtPRKAsGPPVsELItKAVAASKERsG |
| P16403 | S89 | Sugiyama | H1-2 H1F2 HIST1H1C | AGyDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P16403 | T92 | Sugiyama | H1-2 H1F2 HIST1H1C | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P17181 | S535 | PSP | IFNAR1 IFNAR | EETNQTDEDHKKySSQTsQDsGNysNEDESESKTSEELQQD |
| P18615 | S115 | Sugiyama | NELFE RD RDBP | KLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLyEs |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P23528 | S41 | Sugiyama | CFL1 CFL | RKsstPEEVKKRKKAVLFCLsEDKKNIILEEGKEILVGDVG |
| P24534 | S141 | Sugiyama | EEF1B2 EEF1B EF1B | ERLAQYESKKAKKPALVAKssILLDVKPWDDEtDMAKLEEC |
| P25054 | S2129 | Sugiyama | APC DP2.5 | NSIVSSLHQAAAAACLsRQAssDSDSILSLKsGIsLGsPFH |
| P25205 | S447 | Sugiyama | MCM3 | EQGRVTIAKAGIHARLNARCsVLAAANPVyGRyDQyKTPME |
| P25705 | S198 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | GIIPRIsVREPMQTGIKAVDsLVPIGRGQRELIIGDRQTGK |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26373 | S109 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | KVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILFPR |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | S97 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | sLEELRVAGIHKKVARTIGIsVDPRRRNKstEsLQANVQRL |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P29692 | S133 | Sugiyama | EEF1D EF1D | NVLEKssPGHRAtAPQtQHVsPMRQVEPPAKKPAtPAEDDE |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P31327 | S205 | Sugiyama | CPS1 | FEGQPVDFVDPNKQNLIAEVstKDVKVYGKGNPTKVVAVDC |
| P31943 | S269 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQsttGH |
| P33176 | S950 | Sugiyama | KIF5B KNS KNS1 | PAAsPtHPSAIRGGGAFVQNsQPVAVRGGGGKQV_______ |
| P33527 | S915 | Sugiyama | ABCC1 MRP MRP1 | QMENGMLVTDsAGKQLQRQLsssssysGDISRHHNstAELQ |
| P35613 | S246 | Sugiyama | BSG UNQ6505/PRO21383 | VKssEHINEGEtAMLVCKSEsVPPVTDWAWyKITDSEDKAL |
| P36915 | S68 | Sugiyama | GNL1 HSR1 | tDtsDGEsVTHHIRRLNQQPsQGLGPRGYDPNRYRLHFERD |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P41236 | T22 | Sugiyama | PPP1R2 IPP2 | AASTAsHRPIKGILKNKtsttssMVAsAEQPRGNVDEELSK |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46779 | S115 | Sugiyama | RPL28 | HMIRKNKYRPDLRMAAIRRAsAILRSQKPVMVKRKRTRPTK |
| P46779 | S91 | Sugiyama | RPL28 | RKPAtsyVRttINKNARAtLsSIRHMIRKNKYRPDLRMAAI |
| P49588 | S775 | Sugiyama | AARS1 AARS | VTGAEAQKALRKAESLKKCLsVMEAKVKAQTAPNKDVQREI |
| P50552 | S157 | EPSD|PSP | VASP | EVEQQKRQQPGPSEHIERRVsNAGGPPAPPAGGPPPPPGPP |
| P50552 | S239 | EPSD|PSP | VASP | GGAGAPGLAAAIAGAKLRKVsKQEEAsGGPTAPKAESGRSG |
| P50552 | S322 | EPSD|PSP | VASP | QSEsVRRPWEKNstTLPRMKssssVttsEtQPCtPsSSDyS |
| P51532 | S1382 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | EEEKMFGRGSRHRKEVDYsDsLTEKQWLKAIEEGtLEEIEE |
| P51991 | S116 | Sugiyama | HNRNPA3 HNRPA3 | RPHKVDGRVVEPKRAVsREDsVKPGAHLtVKKIFVGGIKED |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P53999 | S12 | Sugiyama | SUB1 PC4 RPO2TC1 | _________MPKSKELVsssssGsDsDsEVDKKLKRKKQVA |
| P55795 | S269 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQstTGH |
| P57772 | S28 | Sugiyama | EEFSEC SELB | VNVGVLGHIDSGKTALARALsTTASTAAFDKQPQSRERGIT |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61221 | Y594 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | RPRINKLNsIKDVEQKKsGNyFFLDD_______________ |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61247 | S238 | Sugiyama | RPS3A FTE1 MFTL | LKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyEP |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62266 | S45 | Sugiyama | RPS23 | KQYKKAHLGtALKANPFGGAsHAKGIVLEKVGVEAKQPNSA |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62826 | T32 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KLVLVGDGGtGKttFVKRHLtGEFEKKyVATLGVEVHPLVF |
| P62857 | S23 | Sugiyama | RPS28 | TSRVQPIKLARVTKVLGRtGsQGQCtQVRVEFMDDtsRsII |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P67809 | Y208 | Sugiyama | YBX1 NSEP1 YB1 | yRRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGE |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P78345 | S253 | Sugiyama | RPP38 | DtsFEDLsKPKRKLADGRQAsVtLQPLKIKKLIPNPNKIRK |
| Q02539 | S92 | Sugiyama | H1-1 H1F1 HIST1H1A | AGyDVEKNNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNK |
| Q02539 | T95 | Sugiyama | H1-1 H1F1 HIST1H1A | DVEKNNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNKKAS |
| Q02880 | S1522 | Sugiyama | TOP2B | DTVPKPKRAPKQKKVVEAVNsDsDsEFGIPKKTTtPKGKGR |
| Q05397 | S677 | Sugiyama | PTK2 FAK FAK1 | KCWAYDPSRRPRFTELKAQLsTILEEEKAQQEERMRMEsRR |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q06210 | T262 | Sugiyama | GFPT1 GFAT GFPT | sQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDAS |
| Q07666 | S35 | Sugiyama | KHDRBS1 SAM68 | sGRsGsMDPsGAHPsVRQtPsRQPPLPHRSRGGGGGSRGGA |
| Q08AD1 | S464 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | FDKEDSVQRstPNRGITRsIsNEGLtLNNsHVsKHIRKNLS |
| Q09028 | S146 | Sugiyama | RBBP4 RBAP48 | EVNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGE |
| Q09028 | S147 | Sugiyama | RBBP4 RBAP48 | VNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGEC |
| Q13563 | S801 | SIGNOR|EPSD|PSP | PKD2 TRPP1 TRPP2 | DLEKEREDLDLDHssLPRPMssRSFPRSLDDsEEDDDEDSG |
| Q13596 | S229 | Sugiyama | SNX1 | PPPPEKSLIGMTKVKVGKEDsssAEFLEKRRAALERYLQRI |
| Q13671 | S292 | GPS6|EPSD|PSP | RIN1 | GAVPSQTERLPPCQLLRREssVGYRVPAGSGPSLPPMPSLQ |
| Q14126 | S551 | Sugiyama | DSG2 CDHF5 | FSVIDKPPGMAEKWKIARQEstsVLLQQSEKKLGRSEIQFL |
| Q14247 | S298 | PSP | CTTN EMS1 | ERQDsAAVGFDyKEKLAKHEsQQDySKGFGGKyGVQKDRMD |
| Q14566 | S498 | Sugiyama | MCM6 | EQQTISITKAGVKATLNARTsILAAANPIsGHyDRSKSLKQ |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15172 | S472 | Sugiyama | PPP2R5A | EELWKKLEELKLKKALEKQNsAyNMHSILSNTSAE______ |
| Q15459 | S690 | Sugiyama | SF3A1 SAP114 | VHPPPPMEDEPTSKKLKTEDsLMPEEEFLRRNKGPVSIKVQ |
| Q15785 | S93 | Sugiyama | TOMM34 URCC3 | DCTSALALVPFSIKPLLRRAsAyEALEKYPMAYVDYKTVLQ |
| Q16204 | S323 | Sugiyama | CCDC6 D10S170 TST1 | RLQRKLQREMERREALCRQLsEsEssLEMDDERYFNEMsAQ |
| Q16576 | S145 | Sugiyama | RBBP7 RBAP46 | EVNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGE |
| Q16576 | S146 | Sugiyama | RBBP7 RBAP46 | VNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGEC |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q53EL6 | S80 | Sugiyama | PDCD4 H731 | KRRLRKNssRDsGRGDsVsDsGsDALRSGLtVPtsPKGRLL |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q5RKV6 | S14 | Sugiyama | EXOSC6 MTR3 | _______MPGDHRRIRGPEEsQPPQLyAADEEEAPGTRDPT |
| Q5UIP0 | S1688 | Sugiyama | RIF1 | PVPESNLRTRNAIKRLHKRDsFDNCsLGESSKIGIsDIssL |
| Q6FI81 | T250 | Sugiyama | CIAPIN1 CUA001 PRO0915 | ASLRAASCGEGKKRKACKNCtCGLAEELEKEKSREQMSSQP |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q7KZI7 | S400 | EPSD|PSP | MARK2 EMK1 | sADLtNssAPsPsHKVQRsVsANPKQRRFsDQAAGPAIPTS |
| Q86VQ1 | S206 | Sugiyama | GLCCI1 | PRDPHVHYPSCMKDKATQTPsCWAEEGAEKRSHQRsAsWGs |
| Q86W56 | S286 | Sugiyama | PARG | VGSEDVGTGPKNDNKLTRQEsCLGNsPPFEKESEPEsPMDV |
| Q8N1G4 | T371 | Sugiyama | LRRC47 KIAA1185 | ALKRFLTSQTKLHEDLCEKRtAAtLAtHELRAVKGPLLYCA |
| Q8NBP7 | S225 | Sugiyama | PCSK9 NARC1 PSEC0052 | FENVPEEDGTRFHRQASKCDsHGtHLAGVVSGRDAGVAKGA |
| Q8NI08 | S208 | Sugiyama | NCOA7 ERAP140 ESNA1 Nbla00052 Nbla10993 | DKLPDADLARKALKPIERVLsstsEEDEPGVVKFLKMNCRY |
| Q8NI08 | S441 | Sugiyama | NCOA7 ERAP140 ESNA1 Nbla00052 Nbla10993 | ELSsQTGGGMHKKDTLKECLsLDPEERKKAESQINNSAVEM |
| Q8WUI4 | S155 | SIGNOR | HDAC7 HDAC7A | PPVPSLPSDPPEHFPLRKtVsEPNLKLRYKPKKSLERRKNP |
| Q8WUI4 | S181 | GPS6|EPSD|PSP | HDAC7 HDAC7A | LRYKPKKSLERRKNPLLRKEsAPPSLRRRPAETLGDSSPSS |
| Q8WUI4 | S358 | SIGNOR | HDAC7 HDAC7A | LMTTERLSGSGLHWPLSRtRsEPLPPSATAPPPPGPMQPRL |
| Q8WYL5 | S937 | SIGNOR|EPSD|PSP | SSH1 KIAA1298 SSH1L | KTICYtPTSSSMSSNLTRsssSDSIHsVRGKPGLVKQRTQE |
| Q8WYL5 | S978 | SIGNOR|EPSD|PSP | SSH1 KIAA1298 SSH1L | IETRLRLAGLTVssPLKRSHsLAKLGsLtFstEDLsSEADP |
| Q92625 | S663 | Sugiyama | ANKS1A ANKS1 KIAA0229 ODIN | sRsEsLsNCsIGKKRLEKsPsFAsEWDEIEKIMssIGEGID |
| Q96G46 | S236 | Sugiyama | DUS3L | QQLRKREVRFERAEQALRRFsQGPtPAAAVPEGTAAEGAPR |
| Q96N67 | S1432 | Sugiyama | DOCK7 KIAA1771 | RRSRGQLGTYTIAsPPERsPsGsAFGsQENLRWRKDMTHWR |
| Q99543 | S275 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | RAQRKKEEMNRIRtLVDNAysCDPRIKKFKEEEKAKKEAEK |
| Q99575 | S816 | Sugiyama | POP1 KIAA0061 | VAATGSHLCVLRSRKLLKQLsAWCGPSSEDSRGGRRAPGRG |
| Q99828 | S78 | EPSD|PSP | CIB1 CIB KIP PRKDCIP | ILSLPELKANPFKERICRVFsTSPAKDSLSFEDFLDLLSVF |
| Q9BXP5 | S422 | Sugiyama | SRRT ARS2 ASR2 | EKPKDAAGLECKPRPLHKTCsLFMRNIAPNISRAEIIsLCK |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BZL6 | S183 | Sugiyama | PRKD2 PKD2 HSPC187 | VRQGLKCDGCGLNYHKRCAFsIPNNCsGARKRRLsstsLAs |
| Q9BZL6 | S189 | Sugiyama | PRKD2 PKD2 HSPC187 | CDGCGLNYHKRCAFsIPNNCsGARKRRLsstsLAsGHsVRL |
| Q9BZL6 | S197 | Sugiyama | PRKD2 PKD2 HSPC187 | HKRCAFsIPNNCsGARKRRLsstsLAsGHsVRLGtsEsLPC |
| Q9BZL6 | S198 | Sugiyama | PRKD2 PKD2 HSPC187 | KRCAFsIPNNCsGARKRRLsstsLAsGHsVRLGtsEsLPCT |
| Q9BZL6 | S200 | Sugiyama | PRKD2 PKD2 HSPC187 | CAFsIPNNCsGARKRRLsstsLAsGHsVRLGtsEsLPCTAE |
| Q9BZL6 | S206 | Sugiyama | PRKD2 PKD2 HSPC187 | NNCsGARKRRLsstsLAsGHsVRLGtsEsLPCTAEELsRst |
| Q9BZL6 | S214 | Sugiyama | PRKD2 PKD2 HSPC187 | RRLsstsLAsGHsVRLGtsEsLPCTAEELsRsttELLPRRP |
| Q9BZL6 | S223 | Sugiyama | PRKD2 PKD2 HSPC187 | sGHsVRLGtsEsLPCTAEELsRsttELLPRRPPsssssssA |
| Q9BZL6 | S237 | Sugiyama | PRKD2 PKD2 HSPC187 | CTAEELsRsttELLPRRPPsssssssAssYTGRPIELDKML |
| Q9BZL6 | S240 | Sugiyama | PRKD2 PKD2 HSPC187 | EELsRsttELLPRRPPsssssssAssYTGRPIELDKMLLSK |
| Q9BZL6 | S241 | Sugiyama | PRKD2 PKD2 HSPC187 | ELsRsttELLPRRPPsssssssAssYTGRPIELDKMLLSKV |
| Q9BZL6 | S353 | Sugiyama | PRKD2 PKD2 HSPC187 | SEADKSALMDESEDsGVIPGsHsENALHAsEEEEGEGGKAQ |
| Q9BZL6 | S362 | Sugiyama | PRKD2 PKD2 HSPC187 | DESEDsGVIPGsHsENALHAsEEEEGEGGKAQssLGyIPLM |
| Q9BZL6 | S374 | Sugiyama | PRKD2 PKD2 HSPC187 | HsENALHAsEEEEGEGGKAQssLGyIPLMRVVQSVRHTTRK |
| Q9BZL6 | S375 | Sugiyama | PRKD2 PKD2 HSPC187 | sENALHAsEEEEGEGGKAQssLGyIPLMRVVQSVRHTTRKs |
| Q9BZL6 | S408 | Sugiyama | PRKD2 PKD2 HSPC187 | VRHTTRKsstTLREGWVVHysNKDTLRKRHYWRLDCKCITL |
| Q9BZL6 | S710 | Sugiyama | PRKD2 PKD2 HSPC187 | QVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLLNQGyNR |
| Q9BZL6 | S876 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PRKD2 PKD2 HSPC187 | DLGGACPPQDHDMQGLAERIsVL__________________ |
| Q9BZL6 | T199 | Sugiyama | PRKD2 PKD2 HSPC187 | RCAFsIPNNCsGARKRRLsstsLAsGHsVRLGtsEsLPCTA |
| Q9BZL6 | T211 | Sugiyama | PRKD2 PKD2 HSPC187 | ARKRRLsstsLAsGHsVRLGtsEsLPCTAEELsRsttELLP |
| Q9BZL6 | T227 | Sugiyama | PRKD2 PKD2 HSPC187 | VRLGtsEsLPCTAEELsRsttELLPRRPPsssssssAssYT |
| Q9BZL6 | T433 | Sugiyama | PRKD2 PKD2 HSPC187 | LRKRHYWRLDCKCITLFQNNtTNRYyKEIPLSEILTVESAQ |
| Q9BZL6 | T502 | Sugiyama | PRKD2 PKD2 HSPC187 | PGGTPGGPSGQGAEAARGWEtAIRQALMPVILQDAPsAPGH |
| Q9BZL6 | T714 | Sugiyama | PRKD2 PKD2 HSPC187 | CDFGFARIIGEKsFRRsVVGtPAyLAPEVLLNQGyNRSLDM |
| Q9BZL6 | Y378 | Sugiyama | PRKD2 PKD2 HSPC187 | ALHAsEEEEGEGGKAQssLGyIPLMRVVQSVRHTTRKsstT |
| Q9BZL6 | Y407 | Sugiyama | PRKD2 PKD2 HSPC187 | SVRHTTRKsstTLREGWVVHysNKDTLRKRHYWRLDCKCIT |
| Q9BZL6 | Y717 | Sugiyama | PRKD2 PKD2 HSPC187 | GFARIIGEKsFRRsVVGtPAyLAPEVLLNQGyNRSLDMWSV |
| Q9BZL6 | Y728 | Sugiyama | PRKD2 PKD2 HSPC187 | RRsVVGtPAyLAPEVLLNQGyNRSLDMWSVGVIMYVSLSGT |
| Q9C0C9 | S399 | Sugiyama | UBE2O KIAA1734 | EGsMAKKVKRLLKKQVVRIMsCsPDtQCsRDHsMEDPDKKG |
| Q9GZY8 | S155 | SIGNOR | MFF C2orf33 AD030 AD033 GL004 | PPttPQNEEIRAVGRLKRERsMsENAVRQNGQLVRNDsLWH |
| Q9GZY8 | S172 | SIGNOR|PSP | MFF C2orf33 AD030 AD033 GL004 | RERsMsENAVRQNGQLVRNDsLWHRsDsAPRNKISRFQAPI |
| Q9GZY8 | S275 | SIGNOR | MFF C2orf33 AD030 AD033 GL004 | RGGsAAAtsNPHHDNVRYGIsNIDTTIEGTSDDLTVVDAAS |
| Q9H0H5 | S206 | Sugiyama | RACGAP1 KIAA1478 MGCRACGAP | tsRQFVDGPPGPVKKtRsIGsAVDQGNEsIVAKTTVTVPND |
| Q9H1H9 | S1698 | Sugiyama | KIF13A RBKIN | GsPSSQSIPEKNSKSLCRtGsCsELDACPSKISQPARGFCP |
| Q9H3N1 | S270 | Sugiyama | TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268 | EAEsKEGtNKDFPQNAIRQRsLGPsLAtDKs__________ |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H9Q2 | S225 | Sugiyama | COPS7B CSN7B | TQQQVEAEVTNIKKTLKAtAsSsAQEMEQQLAERECPPHAE |
| Q9H9Q2 | S227 | Sugiyama | COPS7B CSN7B | QQVEAEVTNIKKTLKAtAsSsAQEMEQQLAERECPPHAEQR |
| Q9UBF8 | S294 | SIGNOR|EPSD|PSP | PI4KB PIK4CB | RsKsDAtAsISLSSNLKRTAsNPKVENEDEELSSSTESIDN |
| Q9UKV8 | S387 | Sugiyama | AGO2 EIF2C2 | ATARSAPDRQEEISKLMRsAsFNTDPyVREFGIMVKDEMTD |
| Q9ULD2 | S1203 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | QENEELKARMDKHMAISRQLstEQAVLQESLEKESKVNKRL |
| Q9ULL1 | S611 | Sugiyama | PLEKHG1 KIAA1209 | GQMESTETSSSGHRIVRRAssAGEsNtCPPEIGTSDRTREL |
| Q9UMZ2 | S752 | Sugiyama | SYNRG AP1GBP1 SYNG | VKGGQNSTAASTKyDVFRQLsLEGsGLGVEDLKDNtPSGKs |
| Q9UNF1 | S264 | Sugiyama | MAGED2 BCG1 | sLRsPKARRGKARRRAAKLQssQEPEAPPPRDVALLQGRAN |
| Q9UQL6 | S259 | SIGNOR | HDAC5 KIAA0600 | KLPLPGPYDSRDDFPLRKTAsEPNLKVRSRLKQKVAERRss |
| Q9UQL6 | S498 | SIGNOR|EPSD|PSP | HDAC5 KIAA0600 | ATSMRTVGKLPRHRPLSRtQssPLPQSPQALQQLVMQQQHQ |
| Q9Y266 | T145 | Sugiyama | NUDC | AENHEAQLKNGsLDsPGKQDtEEDEEEDEKDKGKLKPNLGN |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y580 | S136 | Sugiyama | RBM7 | RyERTMDNMTSSAQIIQRsFssPENFQRQAVMNsALRQMSY |
| Q9Y5B9 | S650 | Sugiyama | SUPT16H FACT140 FACTP140 | KRYKTREAEEKEKEGIVKQDsLVINLNRsNPKLKDLYIRPN |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| G alpha (12/13) signalling events | R-HSA-416482 | 4.806371e-08 | 7.318 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.858669e-08 | 7.313 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.695786e-08 | 7.244 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 7.607288e-07 | 6.119 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.396765e-06 | 5.357 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 9.908842e-06 | 5.004 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.154084e-05 | 4.938 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.465778e-05 | 4.834 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.530042e-05 | 4.815 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.893194e-05 | 4.723 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.430483e-05 | 4.614 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.016973e-05 | 4.520 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.548005e-05 | 4.184 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.374632e-05 | 4.132 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.846598e-05 | 4.105 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.109462e-04 | 3.955 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.719090e-04 | 3.765 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.975710e-04 | 3.704 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.806329e-04 | 3.552 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.158403e-04 | 3.501 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.158403e-04 | 3.501 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.037157e-04 | 3.394 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.656628e-04 | 3.247 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.342621e-04 | 3.272 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.697928e-04 | 3.244 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 6.356538e-04 | 3.197 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 8.791573e-04 | 3.056 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 9.294811e-04 | 3.032 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.167530e-03 | 2.933 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.218666e-03 | 2.914 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.331765e-03 | 2.876 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.378353e-03 | 2.861 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.425361e-03 | 2.846 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.683589e-03 | 2.774 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 1.874390e-03 | 2.727 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.879487e-03 | 2.726 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.182601e-03 | 2.661 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.399512e-03 | 2.620 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.710531e-03 | 2.567 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.737814e-03 | 2.563 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.872724e-03 | 2.542 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.872724e-03 | 2.542 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.246725e-03 | 2.489 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.550942e-03 | 2.450 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.741550e-03 | 2.427 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.143695e-03 | 2.383 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.223514e-03 | 2.374 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 4.489494e-03 | 2.348 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.662172e-03 | 2.331 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.999610e-03 | 2.301 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 5.332182e-03 | 2.273 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.684621e-03 | 2.245 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.135390e-03 | 2.212 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.240369e-03 | 2.205 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.162668e-03 | 2.145 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 8.022119e-03 | 2.096 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 7.790686e-03 | 2.108 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 8.312566e-03 | 2.080 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 9.279286e-03 | 2.032 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 9.106338e-03 | 2.041 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 9.838662e-03 | 2.007 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.106126e-02 | 1.956 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.074123e-02 | 1.969 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.074123e-02 | 1.969 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.074123e-02 | 1.969 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.074123e-02 | 1.969 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.049449e-02 | 1.979 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.075983e-02 | 1.968 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.049449e-02 | 1.979 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.203464e-02 | 1.920 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.203464e-02 | 1.920 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.203464e-02 | 1.920 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.229441e-02 | 1.910 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.298285e-02 | 1.887 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.305937e-02 | 1.884 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.448855e-02 | 1.839 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.448855e-02 | 1.839 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.373101e-02 | 1.862 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.411576e-02 | 1.850 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.448855e-02 | 1.839 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.373101e-02 | 1.862 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.586368e-02 | 1.800 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.781520e-02 | 1.749 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.795489e-02 | 1.746 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.795489e-02 | 1.746 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.892879e-02 | 1.723 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.892879e-02 | 1.723 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.111457e-02 | 1.675 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.356052e-02 | 1.628 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.356052e-02 | 1.628 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.356052e-02 | 1.628 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.356052e-02 | 1.628 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.342571e-02 | 1.630 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.342571e-02 | 1.630 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.307892e-02 | 1.637 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.373545e-02 | 1.625 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.587832e-02 | 1.587 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.788962e-02 | 1.555 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.038188e-02 | 1.517 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.038188e-02 | 1.517 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.038188e-02 | 1.517 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.903679e-02 | 1.537 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.045630e-02 | 1.516 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.311044e-02 | 1.480 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.155079e-02 | 1.501 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.311044e-02 | 1.480 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.233841e-02 | 1.490 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.233841e-02 | 1.490 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 3.233841e-02 | 1.490 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.091244e-02 | 1.510 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.155079e-02 | 1.501 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.289387e-02 | 1.483 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.832811e-02 | 1.416 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.832811e-02 | 1.416 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.832811e-02 | 1.416 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.832811e-02 | 1.416 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.832811e-02 | 1.416 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.568340e-02 | 1.448 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.796730e-02 | 1.421 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.832811e-02 | 1.416 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.879615e-02 | 1.411 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.879615e-02 | 1.411 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.879615e-02 | 1.411 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.934380e-02 | 1.405 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.958933e-02 | 1.402 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.128435e-02 | 1.384 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 4.274298e-02 | 1.369 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 4.284059e-02 | 1.368 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.432942e-02 | 1.353 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.662988e-02 | 1.331 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.730120e-02 | 1.325 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.730120e-02 | 1.325 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.447084e-02 | 1.352 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 4.743179e-02 | 1.324 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.908662e-02 | 1.309 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.908662e-02 | 1.309 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.949029e-02 | 1.305 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.970731e-02 | 1.304 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 5.038047e-02 | 1.298 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 5.038047e-02 | 1.298 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.076600e-02 | 1.294 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.770929e-02 | 1.239 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.403924e-02 | 1.267 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.537571e-02 | 1.257 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.360777e-02 | 1.271 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 5.298097e-02 | 1.276 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.441469e-02 | 1.264 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.779246e-02 | 1.238 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.782894e-02 | 1.238 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.862470e-02 | 1.232 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 5.956329e-02 | 1.225 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.993191e-02 | 1.222 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 5.993191e-02 | 1.222 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 5.993191e-02 | 1.222 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.993191e-02 | 1.222 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.083409e-02 | 1.216 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 6.507278e-02 | 1.187 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 6.224632e-02 | 1.206 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.702501e-02 | 1.174 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 6.816554e-02 | 1.166 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.543938e-02 | 1.184 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 6.816554e-02 | 1.166 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.346851e-02 | 1.197 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 6.507278e-02 | 1.187 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.543938e-02 | 1.184 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 6.824970e-02 | 1.166 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 6.824970e-02 | 1.166 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 7.738154e-02 | 1.111 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 7.738154e-02 | 1.111 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 7.738154e-02 | 1.111 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 7.738154e-02 | 1.111 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 7.738154e-02 | 1.111 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 7.738154e-02 | 1.111 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 7.738154e-02 | 1.111 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 7.738154e-02 | 1.111 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 7.738154e-02 | 1.111 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 7.738154e-02 | 1.111 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 7.738154e-02 | 1.111 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.986431e-02 | 1.156 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.986431e-02 | 1.156 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.986431e-02 | 1.156 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.986431e-02 | 1.156 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.986431e-02 | 1.156 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 6.946173e-02 | 1.158 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 7.727080e-02 | 1.112 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.968271e-02 | 1.157 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.727080e-02 | 1.112 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.986431e-02 | 1.156 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 6.946173e-02 | 1.158 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 7.765537e-02 | 1.110 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 7.856874e-02 | 1.105 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 7.942659e-02 | 1.100 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.942659e-02 | 1.100 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 8.068857e-02 | 1.093 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.075167e-02 | 1.093 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.177352e-02 | 1.087 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 8.201246e-02 | 1.086 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 8.258970e-02 | 1.083 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 8.258970e-02 | 1.083 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 8.543792e-02 | 1.068 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 8.777840e-02 | 1.057 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 9.505835e-02 | 1.022 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.204218e-02 | 1.036 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 8.543792e-02 | 1.068 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 9.505835e-02 | 1.022 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.478416e-02 | 1.072 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.394760e-02 | 1.027 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 8.416061e-02 | 1.075 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.443217e-02 | 1.025 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 9.239436e-02 | 1.034 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 9.239436e-02 | 1.034 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.553917e-02 | 1.020 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 9.615386e-02 | 1.017 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.079257e-01 | 0.967 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.079257e-01 | 0.967 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.042091e-01 | 0.690 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.042091e-01 | 0.690 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.042091e-01 | 0.690 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.042091e-01 | 0.690 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.042091e-01 | 0.690 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.042091e-01 | 0.690 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.042091e-01 | 0.690 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.042091e-01 | 0.690 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.042091e-01 | 0.690 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.042091e-01 | 0.690 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.042091e-01 | 0.690 | 0 | 0 |
| Defective SLC2A10 causes arterial tortuosity syndrome (ATS) | R-HSA-5619068 | 2.042091e-01 | 0.690 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 1.124298e-01 | 0.949 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 1.124298e-01 | 0.949 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.506616e-01 | 0.822 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 1.506616e-01 | 0.822 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.506616e-01 | 0.822 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.506616e-01 | 0.822 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 1.506616e-01 | 0.822 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.506616e-01 | 0.822 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 1.506616e-01 | 0.822 | 0 | 0 |
| FGFR4 mutant receptor activation | R-HSA-1839128 | 2.901055e-01 | 0.537 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 2.901055e-01 | 0.537 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.901055e-01 | 0.537 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.901055e-01 | 0.537 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 2.901055e-01 | 0.537 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 2.901055e-01 | 0.537 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.901055e-01 | 0.537 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.901055e-01 | 0.537 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 2.901055e-01 | 0.537 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 2.901055e-01 | 0.537 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 2.901055e-01 | 0.537 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.901055e-01 | 0.537 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.901055e-01 | 0.537 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.901055e-01 | 0.537 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 2.901055e-01 | 0.537 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.901055e-01 | 0.537 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.081342e-01 | 0.966 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.081342e-01 | 0.966 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.081342e-01 | 0.966 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.909824e-01 | 0.719 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.909824e-01 | 0.719 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 1.909824e-01 | 0.719 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.909824e-01 | 0.719 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.328713e-01 | 0.877 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.593459e-01 | 0.798 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.593459e-01 | 0.798 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.324966e-01 | 0.634 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.324966e-01 | 0.634 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 2.324966e-01 | 0.634 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.324966e-01 | 0.634 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.324966e-01 | 0.634 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 2.324966e-01 | 0.634 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 2.324966e-01 | 0.634 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.667348e-01 | 0.436 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.667348e-01 | 0.436 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 3.667348e-01 | 0.436 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.667348e-01 | 0.436 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.872530e-01 | 0.728 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.872530e-01 | 0.728 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.872530e-01 | 0.728 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.529561e-01 | 0.815 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.744774e-01 | 0.561 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.744774e-01 | 0.561 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 2.744774e-01 | 0.561 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 2.744774e-01 | 0.561 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.744774e-01 | 0.561 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.262320e-01 | 0.899 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.262320e-01 | 0.899 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.162947e-01 | 0.665 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.746554e-01 | 0.758 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.746554e-01 | 0.758 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 1.183708e-01 | 0.927 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.608565e-01 | 0.794 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.973273e-01 | 0.705 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.461862e-01 | 0.609 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.461862e-01 | 0.609 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 2.461862e-01 | 0.609 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.163409e-01 | 0.500 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.163409e-01 | 0.500 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.163409e-01 | 0.500 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 3.163409e-01 | 0.500 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.163409e-01 | 0.500 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.163409e-01 | 0.500 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.350965e-01 | 0.361 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.350965e-01 | 0.361 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.350965e-01 | 0.361 | 0 | 0 |
| Defective GSS causes GSS deficiency | R-HSA-5579006 | 4.350965e-01 | 0.361 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 4.350965e-01 | 0.361 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.350965e-01 | 0.361 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.350965e-01 | 0.361 | 0 | 0 |
| Phenylketonuria | R-HSA-2160456 | 4.350965e-01 | 0.361 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 4.350965e-01 | 0.361 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.350965e-01 | 0.361 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.350965e-01 | 0.361 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.020893e-01 | 0.991 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.475656e-01 | 0.831 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.794597e-01 | 0.746 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.352295e-01 | 0.869 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.766600e-01 | 0.558 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.766600e-01 | 0.558 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.136358e-01 | 0.944 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.796551e-01 | 0.746 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.796551e-01 | 0.746 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.576237e-01 | 0.447 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 3.576237e-01 | 0.447 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.576237e-01 | 0.447 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.576237e-01 | 0.447 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.576237e-01 | 0.447 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.628511e-01 | 0.788 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.134423e-01 | 0.945 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.966638e-01 | 0.706 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.966638e-01 | 0.706 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.966638e-01 | 0.706 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.074692e-01 | 0.512 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.608454e-01 | 0.794 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.697507e-01 | 0.569 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 2.697507e-01 | 0.569 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.741780e-01 | 0.759 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.741780e-01 | 0.759 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.741780e-01 | 0.759 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 9.815181e-02 | 1.008 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.605737e-01 | 0.584 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.948918e-01 | 0.530 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.948918e-01 | 0.530 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 3.383887e-01 | 0.471 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.979635e-01 | 0.400 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.960819e-01 | 0.304 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.960819e-01 | 0.304 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.960819e-01 | 0.304 | 0 | 0 |
| MPS VI - Maroteaux-Lamy syndrome | R-HSA-2206285 | 4.960819e-01 | 0.304 | 0 | 0 |
| betaKlotho-mediated ligand binding | R-HSA-1307965 | 4.960819e-01 | 0.304 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.960819e-01 | 0.304 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 4.960819e-01 | 0.304 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.960819e-01 | 0.304 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.960819e-01 | 0.304 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.657195e-01 | 0.781 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.426521e-01 | 0.846 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.692165e-01 | 0.433 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.692165e-01 | 0.433 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.692165e-01 | 0.433 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 4.370831e-01 | 0.359 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.755507e-01 | 0.560 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 2.755507e-01 | 0.560 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.260276e-01 | 0.487 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.260276e-01 | 0.487 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.912920e-01 | 0.718 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.086510e-01 | 0.511 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.997731e-01 | 0.398 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.408598e-01 | 0.618 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.408598e-01 | 0.618 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.931409e-01 | 0.533 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.482705e-01 | 0.458 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.482705e-01 | 0.458 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.705921e-01 | 0.431 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.705921e-01 | 0.431 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.705921e-01 | 0.431 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 4.299015e-01 | 0.367 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 4.299015e-01 | 0.367 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.747760e-01 | 0.324 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 4.747760e-01 | 0.324 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.504868e-01 | 0.259 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.504868e-01 | 0.259 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.504868e-01 | 0.259 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.504868e-01 | 0.259 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.504868e-01 | 0.259 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.929174e-01 | 0.406 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.929174e-01 | 0.406 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.575520e-01 | 0.589 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.575520e-01 | 0.589 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 4.594664e-01 | 0.338 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 4.594664e-01 | 0.338 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.474199e-01 | 0.349 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.474199e-01 | 0.349 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 4.474199e-01 | 0.349 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.474199e-01 | 0.349 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 5.108944e-01 | 0.292 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.108944e-01 | 0.292 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.108944e-01 | 0.292 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.108944e-01 | 0.292 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.108944e-01 | 0.292 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.703298e-01 | 0.431 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.284570e-01 | 0.368 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.853509e-01 | 0.414 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.592276e-01 | 0.338 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.388328e-01 | 0.358 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.680675e-01 | 0.330 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.164640e-01 | 0.287 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.453389e-01 | 0.263 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.453389e-01 | 0.263 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.453389e-01 | 0.263 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.453389e-01 | 0.263 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.453389e-01 | 0.263 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.990208e-01 | 0.223 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.990208e-01 | 0.223 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.990208e-01 | 0.223 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.990208e-01 | 0.223 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.990208e-01 | 0.223 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.990208e-01 | 0.223 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.990208e-01 | 0.223 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.990208e-01 | 0.223 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.990208e-01 | 0.223 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 5.990208e-01 | 0.223 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 5.990208e-01 | 0.223 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.022741e-01 | 0.299 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 5.202482e-01 | 0.284 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.930384e-01 | 0.307 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 5.780501e-01 | 0.238 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.780501e-01 | 0.238 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 5.780501e-01 | 0.238 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 5.780501e-01 | 0.238 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 5.700650e-01 | 0.244 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 5.700650e-01 | 0.244 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 5.810519e-01 | 0.236 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.881993e-01 | 0.230 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 5.954446e-01 | 0.225 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 6.090006e-01 | 0.215 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.090006e-01 | 0.215 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 6.090006e-01 | 0.215 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.090006e-01 | 0.215 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.423170e-01 | 0.192 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.423170e-01 | 0.192 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.423170e-01 | 0.192 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.026935e-01 | 0.220 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.381894e-01 | 0.195 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.381894e-01 | 0.195 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 6.381894e-01 | 0.195 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.381894e-01 | 0.195 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.381894e-01 | 0.195 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.431876e-01 | 0.192 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.693834e-01 | 0.174 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.656360e-01 | 0.177 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 6.809406e-01 | 0.167 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.809406e-01 | 0.167 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.809406e-01 | 0.167 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.809406e-01 | 0.167 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.809406e-01 | 0.167 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.809406e-01 | 0.167 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.805578e-01 | 0.552 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.232078e-01 | 0.373 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.700650e-01 | 0.244 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.700650e-01 | 0.244 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 4.594664e-01 | 0.338 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 4.594664e-01 | 0.338 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.237391e-01 | 0.650 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.017915e-01 | 0.695 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.697507e-01 | 0.569 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.630932e-01 | 0.580 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.711640e-01 | 0.173 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.151752e-01 | 0.382 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.140142e-01 | 0.289 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 6.245314e-01 | 0.204 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 2.683036e-01 | 0.571 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.884146e-01 | 0.411 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.780501e-01 | 0.238 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 6.095576e-01 | 0.215 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.328735e-01 | 0.364 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.328735e-01 | 0.364 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 2.208290e-01 | 0.656 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 3.273481e-01 | 0.485 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.453389e-01 | 0.263 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 6.501669e-01 | 0.187 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.328735e-01 | 0.364 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 6.427029e-01 | 0.192 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.931409e-01 | 0.533 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.544562e-01 | 0.594 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 4.021789e-01 | 0.396 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 4.758140e-01 | 0.323 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 1.608565e-01 | 0.794 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.119559e-01 | 0.951 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.475707e-01 | 0.262 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.381894e-01 | 0.195 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.657463e-01 | 0.177 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.230296e-01 | 0.374 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.775378e-01 | 0.751 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.692165e-01 | 0.433 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.625172e-01 | 0.250 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.593459e-01 | 0.798 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.136358e-01 | 0.944 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.628511e-01 | 0.788 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.394618e-01 | 0.621 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.453149e-01 | 0.462 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.693924e-01 | 0.433 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.259213e-01 | 0.279 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.514928e-01 | 0.599 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.378011e-01 | 0.195 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 4.299015e-01 | 0.367 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.222972e-01 | 0.282 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.198264e-01 | 0.208 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.987825e-01 | 0.399 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.205337e-01 | 0.376 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.141249e-01 | 0.289 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.163409e-01 | 0.500 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.163409e-01 | 0.500 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.834028e-01 | 0.416 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.656360e-01 | 0.177 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.876989e-01 | 0.312 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.553732e-01 | 0.449 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.284152e-01 | 0.484 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.881993e-01 | 0.230 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.111247e-01 | 0.507 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.838072e-01 | 0.416 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.426998e-01 | 0.465 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.385577e-01 | 0.358 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.506616e-01 | 0.822 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.576237e-01 | 0.447 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.979635e-01 | 0.400 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.067673e-01 | 0.972 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.108944e-01 | 0.292 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 5.453389e-01 | 0.263 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.661716e-01 | 0.247 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.838381e-01 | 0.234 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.492221e-01 | 0.348 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.146035e-01 | 0.382 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.128843e-01 | 0.672 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 5.838381e-01 | 0.234 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.956069e-01 | 0.225 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.039421e-01 | 0.517 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.913104e-01 | 0.407 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.872530e-01 | 0.728 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.127229e-01 | 0.948 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.632718e-01 | 0.787 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.453389e-01 | 0.263 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.734711e-01 | 0.761 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.094937e-01 | 0.961 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.050689e-01 | 0.979 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.931409e-01 | 0.533 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 4.592276e-01 | 0.338 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.857679e-01 | 0.544 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 4.875996e-01 | 0.312 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.831017e-01 | 0.737 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.761161e-01 | 0.170 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.257471e-01 | 0.487 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.747556e-01 | 0.324 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.593459e-01 | 0.798 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.324966e-01 | 0.634 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.529561e-01 | 0.815 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.163409e-01 | 0.500 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.576237e-01 | 0.447 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.628511e-01 | 0.788 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.074692e-01 | 0.512 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.611219e-01 | 0.793 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.611219e-01 | 0.793 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.611219e-01 | 0.793 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.611219e-01 | 0.793 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.891010e-01 | 0.539 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.260276e-01 | 0.487 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 3.997731e-01 | 0.398 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 3.997731e-01 | 0.398 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 4.299015e-01 | 0.367 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.747760e-01 | 0.324 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.504868e-01 | 0.259 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.504868e-01 | 0.259 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.721436e-01 | 0.326 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.066358e-01 | 0.391 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.068963e-01 | 0.295 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 6.090006e-01 | 0.215 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 6.693834e-01 | 0.174 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.809406e-01 | 0.167 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 6.809406e-01 | 0.167 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.257773e-01 | 0.487 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.539016e-01 | 0.451 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.860177e-01 | 0.730 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.643111e-01 | 0.248 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.643111e-01 | 0.248 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.473661e-01 | 0.607 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.473661e-01 | 0.607 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.412705e-01 | 0.617 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.195193e-01 | 0.496 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.809033e-01 | 0.318 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.294042e-01 | 0.367 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 3.883186e-01 | 0.411 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.525665e-01 | 0.453 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.697507e-01 | 0.569 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.747760e-01 | 0.324 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.471742e-01 | 0.459 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.881993e-01 | 0.230 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.262320e-01 | 0.899 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.698249e-01 | 0.569 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.701938e-01 | 0.568 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 5.780501e-01 | 0.238 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.439175e-01 | 0.264 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.592276e-01 | 0.338 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.786715e-01 | 0.422 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.780501e-01 | 0.238 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.090031e-01 | 0.963 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 2.744774e-01 | 0.561 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.262320e-01 | 0.899 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 4.350965e-01 | 0.361 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.960819e-01 | 0.304 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 2.891010e-01 | 0.539 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.370831e-01 | 0.359 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.504868e-01 | 0.259 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.805578e-01 | 0.552 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.594664e-01 | 0.338 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 4.594664e-01 | 0.338 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.990208e-01 | 0.223 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.875996e-01 | 0.312 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.423170e-01 | 0.192 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.423170e-01 | 0.192 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.381894e-01 | 0.195 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 6.381894e-01 | 0.195 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.427029e-01 | 0.192 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.047658e-01 | 0.980 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.654584e-01 | 0.437 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.883526e-01 | 0.311 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.656008e-01 | 0.247 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.154544e-01 | 0.381 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 4.299015e-01 | 0.367 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.964413e-01 | 0.304 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.455364e-01 | 0.263 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 6.090006e-01 | 0.215 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.423170e-01 | 0.192 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.792510e-01 | 0.168 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.375899e-01 | 0.472 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.561542e-01 | 0.341 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.831017e-01 | 0.737 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.591760e-01 | 0.181 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.979635e-01 | 0.400 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.594664e-01 | 0.338 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.656360e-01 | 0.177 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 5.988788e-01 | 0.223 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.016457e-01 | 0.993 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.226085e-01 | 0.374 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 4.964413e-01 | 0.304 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.637358e-01 | 0.249 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.474199e-01 | 0.349 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 4.721436e-01 | 0.326 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.625172e-01 | 0.250 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.609792e-01 | 0.180 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.656360e-01 | 0.177 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.459360e-01 | 0.263 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.796551e-01 | 0.746 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.501669e-01 | 0.187 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.086643e-01 | 0.964 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.880682e-01 | 0.312 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.042091e-01 | 0.690 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.124298e-01 | 0.949 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.506616e-01 | 0.822 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 3.667348e-01 | 0.436 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.667348e-01 | 0.436 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.667348e-01 | 0.436 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.529561e-01 | 0.815 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 2.162947e-01 | 0.665 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.350965e-01 | 0.361 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.350965e-01 | 0.361 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.766600e-01 | 0.558 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.576237e-01 | 0.447 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.697507e-01 | 0.569 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.370831e-01 | 0.359 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.544562e-01 | 0.594 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.747760e-01 | 0.324 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 5.504868e-01 | 0.259 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.504868e-01 | 0.259 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.504868e-01 | 0.259 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.051720e-01 | 0.515 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 5.108944e-01 | 0.292 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.883526e-01 | 0.311 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.151318e-01 | 0.502 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.964413e-01 | 0.304 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.990208e-01 | 0.223 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 5.990208e-01 | 0.223 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.232930e-01 | 0.281 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.259213e-01 | 0.279 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.435077e-01 | 0.265 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 5.700650e-01 | 0.244 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.661716e-01 | 0.247 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 5.661716e-01 | 0.247 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.755886e-01 | 0.240 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 6.090006e-01 | 0.215 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.905780e-01 | 0.229 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 6.030730e-01 | 0.220 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.217908e-01 | 0.206 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.217908e-01 | 0.206 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 6.693834e-01 | 0.174 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.809406e-01 | 0.167 | 0 | 0 |
| Cysteine formation from homocysteine | R-HSA-1614603 | 6.809406e-01 | 0.167 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.945880e-01 | 0.711 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.945880e-01 | 0.711 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.287387e-01 | 0.202 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.683532e-01 | 0.434 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.917626e-01 | 0.228 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 5.022741e-01 | 0.299 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 4.753102e-01 | 0.323 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 4.964413e-01 | 0.304 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.453887e-01 | 0.837 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.198264e-01 | 0.208 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.273481e-01 | 0.485 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.606346e-01 | 0.337 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.439175e-01 | 0.264 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.446418e-01 | 0.264 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.628511e-01 | 0.788 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.164640e-01 | 0.287 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.465266e-01 | 0.262 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 6.204153e-01 | 0.207 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.693834e-01 | 0.174 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.809406e-01 | 0.167 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.879840e-01 | 0.726 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.680675e-01 | 0.330 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.501060e-01 | 0.824 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.508830e-01 | 0.601 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.100180e-01 | 0.509 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.962614e-01 | 0.402 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.918391e-01 | 0.535 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.205337e-01 | 0.376 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.205337e-01 | 0.376 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 3.576237e-01 | 0.447 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.370831e-01 | 0.359 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 4.299015e-01 | 0.367 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.260792e-01 | 0.899 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.486438e-01 | 0.261 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 5.068963e-01 | 0.295 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.095576e-01 | 0.215 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.887205e-01 | 0.410 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.474199e-01 | 0.349 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.474199e-01 | 0.349 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.016349e-01 | 0.300 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 9.735770e-02 | 1.012 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.487374e-01 | 0.828 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.958197e-01 | 0.708 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.154950e-01 | 0.381 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 1.909824e-01 | 0.719 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.593459e-01 | 0.798 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 1.593459e-01 | 0.798 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.324966e-01 | 0.634 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.746554e-01 | 0.758 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.794597e-01 | 0.746 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.074692e-01 | 0.512 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.979635e-01 | 0.400 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.960819e-01 | 0.304 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.969987e-01 | 0.401 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.148011e-01 | 0.502 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.990208e-01 | 0.223 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 5.990208e-01 | 0.223 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.198264e-01 | 0.208 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.579167e-01 | 0.802 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.465266e-01 | 0.262 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.611219e-01 | 0.793 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.037373e-01 | 0.984 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.118517e-01 | 0.385 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.979635e-01 | 0.400 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.518873e-01 | 0.454 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.202482e-01 | 0.284 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.780501e-01 | 0.238 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.780501e-01 | 0.238 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.661716e-01 | 0.247 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 6.656360e-01 | 0.177 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.656360e-01 | 0.177 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.747807e-01 | 0.426 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.337664e-01 | 0.198 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 1.475656e-01 | 0.831 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.697507e-01 | 0.569 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.692165e-01 | 0.433 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 1.966638e-01 | 0.706 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.308149e-01 | 0.883 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.969987e-01 | 0.401 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 2.063866e-01 | 0.685 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.198264e-01 | 0.208 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.901055e-01 | 0.537 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.667348e-01 | 0.436 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.262320e-01 | 0.899 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 2.162947e-01 | 0.665 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.350965e-01 | 0.361 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 3.576237e-01 | 0.447 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 3.074692e-01 | 0.512 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.960819e-01 | 0.304 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.891010e-01 | 0.539 | 0 | 0 |
| LTC4-CYSLTR mediated IL4 production | R-HSA-9664535 | 4.370831e-01 | 0.359 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.332900e-01 | 0.632 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 4.299015e-01 | 0.367 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 4.747760e-01 | 0.324 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.747760e-01 | 0.324 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.504868e-01 | 0.259 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 5.504868e-01 | 0.259 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.504868e-01 | 0.259 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.108944e-01 | 0.292 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 4.964413e-01 | 0.304 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.990208e-01 | 0.223 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.022741e-01 | 0.299 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 5.437223e-01 | 0.265 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.423170e-01 | 0.192 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.656360e-01 | 0.177 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 6.656360e-01 | 0.177 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.809406e-01 | 0.167 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.278476e-01 | 0.369 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.324296e-01 | 0.274 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.554576e-01 | 0.183 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.828224e-01 | 0.548 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.260276e-01 | 0.487 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.954446e-01 | 0.225 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.439175e-01 | 0.264 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 5.437223e-01 | 0.265 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.593459e-01 | 0.798 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 3.802838e-01 | 0.420 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 6.273615e-01 | 0.202 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.609792e-01 | 0.180 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.872530e-01 | 0.728 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.162947e-01 | 0.665 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.108944e-01 | 0.292 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.381894e-01 | 0.195 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.202482e-01 | 0.284 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.860429e-01 | 0.413 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 3.692165e-01 | 0.433 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 4.594664e-01 | 0.338 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 5.437223e-01 | 0.265 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.767589e-01 | 0.239 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.860429e-01 | 0.413 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.789238e-01 | 0.555 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.909824e-01 | 0.719 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 2.324966e-01 | 0.634 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 2.744774e-01 | 0.561 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.163409e-01 | 0.500 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.163409e-01 | 0.500 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 3.576237e-01 | 0.447 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.960819e-01 | 0.304 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.504868e-01 | 0.259 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.504868e-01 | 0.259 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.504868e-01 | 0.259 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.990208e-01 | 0.223 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 5.990208e-01 | 0.223 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.780501e-01 | 0.238 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.423170e-01 | 0.192 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.604808e-01 | 0.180 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.431876e-01 | 0.192 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.656360e-01 | 0.177 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.809406e-01 | 0.167 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 6.809406e-01 | 0.167 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 6.809406e-01 | 0.167 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 2.582456e-01 | 0.588 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.751721e-01 | 0.426 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.804703e-01 | 0.167 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.721436e-01 | 0.326 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.697507e-01 | 0.569 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.453389e-01 | 0.263 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.381894e-01 | 0.195 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 6.381894e-01 | 0.195 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.124938e-01 | 0.213 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.164640e-01 | 0.287 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.164640e-01 | 0.287 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.185946e-01 | 0.660 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.576237e-01 | 0.447 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 4.370831e-01 | 0.359 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 5.504868e-01 | 0.259 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.453389e-01 | 0.263 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.453389e-01 | 0.263 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.453389e-01 | 0.263 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.990208e-01 | 0.223 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.990208e-01 | 0.223 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.090006e-01 | 0.215 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.423170e-01 | 0.192 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.423170e-01 | 0.192 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.381894e-01 | 0.195 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.809406e-01 | 0.167 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.809406e-01 | 0.167 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.623974e-01 | 0.250 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.159235e-01 | 0.210 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.697507e-01 | 0.569 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 2.766600e-01 | 0.558 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.458759e-01 | 0.461 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.439175e-01 | 0.264 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.381894e-01 | 0.195 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.284152e-01 | 0.484 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.504868e-01 | 0.259 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.423170e-01 | 0.192 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 6.030730e-01 | 0.220 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.257471e-01 | 0.487 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.453389e-01 | 0.263 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.656360e-01 | 0.177 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.804703e-01 | 0.167 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.431876e-01 | 0.192 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.370831e-01 | 0.359 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.780501e-01 | 0.238 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.904328e-01 | 0.309 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.090006e-01 | 0.215 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.323357e-01 | 0.634 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 6.561482e-01 | 0.183 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.833996e-01 | 0.165 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.846379e-01 | 0.165 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 6.864436e-01 | 0.163 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.868070e-01 | 0.163 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 6.868070e-01 | 0.163 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.868070e-01 | 0.163 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 6.868070e-01 | 0.163 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.878607e-01 | 0.162 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.913763e-01 | 0.160 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 6.913763e-01 | 0.160 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.913763e-01 | 0.160 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.913763e-01 | 0.160 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.913763e-01 | 0.160 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.913763e-01 | 0.160 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 6.913763e-01 | 0.160 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.913763e-01 | 0.160 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 6.913763e-01 | 0.160 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 6.924136e-01 | 0.160 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.954535e-01 | 0.158 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.004622e-01 | 0.155 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.029402e-01 | 0.153 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 7.031046e-01 | 0.153 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.052286e-01 | 0.152 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.055948e-01 | 0.151 | 0 | 0 |
| S Phase | R-HSA-69242 | 7.058714e-01 | 0.151 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.070660e-01 | 0.151 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.070660e-01 | 0.151 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.153955e-01 | 0.145 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.153955e-01 | 0.145 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.153955e-01 | 0.145 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.153955e-01 | 0.145 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.153955e-01 | 0.145 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.153955e-01 | 0.145 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.153955e-01 | 0.145 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.153955e-01 | 0.145 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.153955e-01 | 0.145 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.153955e-01 | 0.145 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.153955e-01 | 0.145 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.153955e-01 | 0.145 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.153955e-01 | 0.145 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.154587e-01 | 0.145 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 7.154587e-01 | 0.145 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.154587e-01 | 0.145 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.202548e-01 | 0.143 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.204441e-01 | 0.142 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 7.223836e-01 | 0.141 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 7.223836e-01 | 0.141 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.223836e-01 | 0.141 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.223836e-01 | 0.141 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.223836e-01 | 0.141 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 7.225856e-01 | 0.141 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 7.225856e-01 | 0.141 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.239883e-01 | 0.140 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.239883e-01 | 0.140 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.263038e-01 | 0.139 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 7.263038e-01 | 0.139 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 7.263651e-01 | 0.139 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.333456e-01 | 0.135 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 7.354839e-01 | 0.133 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.371258e-01 | 0.132 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.371258e-01 | 0.132 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.375347e-01 | 0.132 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.379409e-01 | 0.132 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 7.379409e-01 | 0.132 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.379409e-01 | 0.132 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 7.379409e-01 | 0.132 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.379409e-01 | 0.132 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.379409e-01 | 0.132 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 7.388373e-01 | 0.131 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.388373e-01 | 0.131 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 7.388373e-01 | 0.131 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 7.391693e-01 | 0.131 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 7.391693e-01 | 0.131 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 7.402176e-01 | 0.131 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 7.438805e-01 | 0.128 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.443970e-01 | 0.128 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.445371e-01 | 0.128 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.445371e-01 | 0.128 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.461315e-01 | 0.127 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.461315e-01 | 0.127 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 7.461315e-01 | 0.127 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.461315e-01 | 0.127 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.461315e-01 | 0.127 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.461315e-01 | 0.127 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.461315e-01 | 0.127 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.461315e-01 | 0.127 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.461315e-01 | 0.127 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.461315e-01 | 0.127 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.461315e-01 | 0.127 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.461315e-01 | 0.127 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.461315e-01 | 0.127 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.461315e-01 | 0.127 | 0 | 0 |
| Lysosomal oligosaccharide catabolism | R-HSA-8853383 | 7.461315e-01 | 0.127 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.461315e-01 | 0.127 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 7.461315e-01 | 0.127 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.461315e-01 | 0.127 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.489169e-01 | 0.126 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 7.512873e-01 | 0.124 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 7.513278e-01 | 0.124 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.513278e-01 | 0.124 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 7.543572e-01 | 0.122 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 7.543720e-01 | 0.122 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.588878e-01 | 0.120 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.588878e-01 | 0.120 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.588878e-01 | 0.120 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.588878e-01 | 0.120 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.617875e-01 | 0.118 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 7.617875e-01 | 0.118 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 7.617875e-01 | 0.118 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.630764e-01 | 0.117 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 7.630764e-01 | 0.117 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.631864e-01 | 0.117 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 7.643414e-01 | 0.117 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.648725e-01 | 0.116 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.659516e-01 | 0.116 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 7.675709e-01 | 0.115 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 7.691557e-01 | 0.114 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 7.708862e-01 | 0.113 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.735497e-01 | 0.112 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.735497e-01 | 0.112 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 7.735497e-01 | 0.112 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 7.735497e-01 | 0.112 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.735497e-01 | 0.112 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.735497e-01 | 0.112 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.735497e-01 | 0.112 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.735497e-01 | 0.112 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.735497e-01 | 0.112 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.735497e-01 | 0.112 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.735497e-01 | 0.112 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.735497e-01 | 0.112 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.735497e-01 | 0.112 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.735497e-01 | 0.112 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.735497e-01 | 0.112 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 7.735497e-01 | 0.112 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 7.735497e-01 | 0.112 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 7.746523e-01 | 0.111 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 7.756426e-01 | 0.110 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.767485e-01 | 0.110 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.771569e-01 | 0.109 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.778878e-01 | 0.109 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.778878e-01 | 0.109 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.780803e-01 | 0.109 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.780803e-01 | 0.109 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.780803e-01 | 0.109 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.780803e-01 | 0.109 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.780803e-01 | 0.109 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.783686e-01 | 0.109 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.783686e-01 | 0.109 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.783686e-01 | 0.109 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.783686e-01 | 0.109 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.832458e-01 | 0.106 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.832458e-01 | 0.106 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.832458e-01 | 0.106 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 7.832458e-01 | 0.106 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 7.832458e-01 | 0.106 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.832458e-01 | 0.106 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 7.839128e-01 | 0.106 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.849735e-01 | 0.105 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.853521e-01 | 0.105 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 7.869363e-01 | 0.104 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 7.869363e-01 | 0.104 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.879119e-01 | 0.104 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 7.934443e-01 | 0.100 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 7.934443e-01 | 0.100 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.949419e-01 | 0.100 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.954740e-01 | 0.099 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.954740e-01 | 0.099 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.954740e-01 | 0.099 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.958860e-01 | 0.099 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.958860e-01 | 0.099 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 7.964556e-01 | 0.099 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.964556e-01 | 0.099 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.964556e-01 | 0.099 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.964556e-01 | 0.099 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.964556e-01 | 0.099 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.964556e-01 | 0.099 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 7.966428e-01 | 0.099 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 7.966428e-01 | 0.099 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.978577e-01 | 0.098 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.980082e-01 | 0.098 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.980082e-01 | 0.098 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 7.980082e-01 | 0.098 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.980082e-01 | 0.098 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.980082e-01 | 0.098 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.980082e-01 | 0.098 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 7.980082e-01 | 0.098 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 7.980082e-01 | 0.098 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.980082e-01 | 0.098 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.980082e-01 | 0.098 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 7.980082e-01 | 0.098 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.981107e-01 | 0.098 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.008594e-01 | 0.096 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.040430e-01 | 0.095 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 8.048782e-01 | 0.094 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.048782e-01 | 0.094 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.048782e-01 | 0.094 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.051315e-01 | 0.094 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.059258e-01 | 0.094 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.059258e-01 | 0.094 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.072596e-01 | 0.093 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.079105e-01 | 0.093 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.088271e-01 | 0.092 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.093637e-01 | 0.092 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.093637e-01 | 0.092 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.093637e-01 | 0.092 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.093637e-01 | 0.092 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.093637e-01 | 0.092 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.093637e-01 | 0.092 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.101702e-01 | 0.091 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 8.111086e-01 | 0.091 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.129774e-01 | 0.090 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.132226e-01 | 0.090 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.132226e-01 | 0.090 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 8.132226e-01 | 0.090 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 8.132226e-01 | 0.090 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 8.132226e-01 | 0.090 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.132226e-01 | 0.090 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.136040e-01 | 0.090 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.198262e-01 | 0.086 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 8.198262e-01 | 0.086 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.198262e-01 | 0.086 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.198262e-01 | 0.086 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.198262e-01 | 0.086 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.198262e-01 | 0.086 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.198262e-01 | 0.086 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.198262e-01 | 0.086 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 8.198262e-01 | 0.086 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 8.198262e-01 | 0.086 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 8.208236e-01 | 0.086 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.208413e-01 | 0.086 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.214269e-01 | 0.085 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 8.214835e-01 | 0.085 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 8.215119e-01 | 0.085 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.215119e-01 | 0.085 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 8.215119e-01 | 0.085 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.244364e-01 | 0.084 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.285499e-01 | 0.082 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.285499e-01 | 0.082 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.287437e-01 | 0.082 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 8.287437e-01 | 0.082 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.287437e-01 | 0.082 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 8.287437e-01 | 0.082 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.287437e-01 | 0.082 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.287437e-01 | 0.082 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.287437e-01 | 0.082 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.289191e-01 | 0.081 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.304228e-01 | 0.081 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 8.304244e-01 | 0.081 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.328529e-01 | 0.079 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.341156e-01 | 0.079 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.342829e-01 | 0.079 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 8.342829e-01 | 0.079 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.342829e-01 | 0.079 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.357683e-01 | 0.078 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.392887e-01 | 0.076 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.392887e-01 | 0.076 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.392887e-01 | 0.076 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.392887e-01 | 0.076 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.392887e-01 | 0.076 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 8.392887e-01 | 0.076 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.392887e-01 | 0.076 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.392887e-01 | 0.076 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.392887e-01 | 0.076 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.392887e-01 | 0.076 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.392887e-01 | 0.076 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.392887e-01 | 0.076 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.392887e-01 | 0.076 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.392887e-01 | 0.076 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.428731e-01 | 0.074 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.430923e-01 | 0.074 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.430923e-01 | 0.074 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.430923e-01 | 0.074 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 8.430923e-01 | 0.074 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.436621e-01 | 0.074 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.452548e-01 | 0.073 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.462587e-01 | 0.072 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.462587e-01 | 0.072 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.462587e-01 | 0.072 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.462587e-01 | 0.072 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.490207e-01 | 0.071 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.491233e-01 | 0.071 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.491233e-01 | 0.071 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.493923e-01 | 0.071 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.526172e-01 | 0.069 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.526172e-01 | 0.069 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.538762e-01 | 0.069 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.538762e-01 | 0.069 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.538762e-01 | 0.069 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 8.538762e-01 | 0.069 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.538981e-01 | 0.069 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.538981e-01 | 0.069 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 8.538981e-01 | 0.069 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 8.562674e-01 | 0.067 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.563405e-01 | 0.067 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.563405e-01 | 0.067 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 8.563405e-01 | 0.067 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.563405e-01 | 0.067 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 8.566498e-01 | 0.067 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.566498e-01 | 0.067 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.566498e-01 | 0.067 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.566498e-01 | 0.067 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.566498e-01 | 0.067 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.566498e-01 | 0.067 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.566498e-01 | 0.067 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.566498e-01 | 0.067 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.566498e-01 | 0.067 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.566498e-01 | 0.067 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.566498e-01 | 0.067 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 8.574751e-01 | 0.067 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 8.577071e-01 | 0.067 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.621864e-01 | 0.064 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.622431e-01 | 0.064 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.635175e-01 | 0.064 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 8.635175e-01 | 0.064 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.679679e-01 | 0.061 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.679679e-01 | 0.061 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.685586e-01 | 0.061 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 8.706568e-01 | 0.060 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.717054e-01 | 0.060 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.718170e-01 | 0.060 | 0 | 0 |
| The activation of arylsulfatases | R-HSA-1663150 | 8.721364e-01 | 0.059 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.721364e-01 | 0.059 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 8.721364e-01 | 0.059 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.721364e-01 | 0.059 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.721364e-01 | 0.059 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.721364e-01 | 0.059 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 8.721364e-01 | 0.059 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.721364e-01 | 0.059 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.721364e-01 | 0.059 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.721364e-01 | 0.059 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 8.721364e-01 | 0.059 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.721364e-01 | 0.059 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.726085e-01 | 0.059 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.730418e-01 | 0.059 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 8.736529e-01 | 0.059 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.736529e-01 | 0.059 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.798145e-01 | 0.056 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.798145e-01 | 0.056 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.798145e-01 | 0.056 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.798145e-01 | 0.056 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.798145e-01 | 0.056 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.805991e-01 | 0.055 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.811718e-01 | 0.055 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.843969e-01 | 0.053 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.843969e-01 | 0.053 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.859508e-01 | 0.053 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.859508e-01 | 0.053 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.859508e-01 | 0.053 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.859508e-01 | 0.053 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.859508e-01 | 0.053 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.859508e-01 | 0.053 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.859508e-01 | 0.053 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.859508e-01 | 0.053 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.859508e-01 | 0.053 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.859508e-01 | 0.053 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.859508e-01 | 0.053 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.859508e-01 | 0.053 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.859508e-01 | 0.053 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.862319e-01 | 0.052 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.862319e-01 | 0.052 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.866597e-01 | 0.052 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.869253e-01 | 0.052 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 8.871218e-01 | 0.052 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.882830e-01 | 0.051 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.882830e-01 | 0.051 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.892302e-01 | 0.051 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.901735e-01 | 0.051 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.901735e-01 | 0.051 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.901735e-01 | 0.051 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.904936e-01 | 0.050 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.937913e-01 | 0.049 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 8.937913e-01 | 0.049 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.968063e-01 | 0.047 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.982734e-01 | 0.047 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.982734e-01 | 0.047 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.982734e-01 | 0.047 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.982734e-01 | 0.047 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.982734e-01 | 0.047 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.982734e-01 | 0.047 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 8.982734e-01 | 0.047 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.982734e-01 | 0.047 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.982734e-01 | 0.047 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.982734e-01 | 0.047 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 8.982734e-01 | 0.047 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 8.982734e-01 | 0.047 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 8.982734e-01 | 0.047 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.982734e-01 | 0.047 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.982734e-01 | 0.047 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.982734e-01 | 0.047 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.993647e-01 | 0.046 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.993647e-01 | 0.046 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 8.996978e-01 | 0.046 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.996978e-01 | 0.046 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.996978e-01 | 0.046 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.003463e-01 | 0.046 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.019184e-01 | 0.045 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.034110e-01 | 0.044 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.034110e-01 | 0.044 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.039224e-01 | 0.044 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.052950e-01 | 0.043 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.064565e-01 | 0.043 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.068973e-01 | 0.042 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.069791e-01 | 0.042 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.084469e-01 | 0.042 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.084469e-01 | 0.042 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.092652e-01 | 0.041 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.092652e-01 | 0.041 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.092652e-01 | 0.041 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.092652e-01 | 0.041 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 9.092652e-01 | 0.041 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.092652e-01 | 0.041 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.092652e-01 | 0.041 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.092652e-01 | 0.041 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.095876e-01 | 0.041 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 9.106300e-01 | 0.041 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.108111e-01 | 0.041 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.108111e-01 | 0.041 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 9.108111e-01 | 0.041 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.118176e-01 | 0.040 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.149625e-01 | 0.039 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.164158e-01 | 0.038 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 9.164409e-01 | 0.038 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.164771e-01 | 0.038 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.164771e-01 | 0.038 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.164771e-01 | 0.038 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.164771e-01 | 0.038 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.168624e-01 | 0.038 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.176925e-01 | 0.037 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.176925e-01 | 0.037 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.185671e-01 | 0.037 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.190699e-01 | 0.037 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 9.190699e-01 | 0.037 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 9.190699e-01 | 0.037 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.190699e-01 | 0.037 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.190699e-01 | 0.037 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.190699e-01 | 0.037 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 9.190699e-01 | 0.037 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.203519e-01 | 0.036 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.205542e-01 | 0.036 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.208559e-01 | 0.036 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.215366e-01 | 0.035 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.227290e-01 | 0.035 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.238416e-01 | 0.034 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.238416e-01 | 0.034 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.238416e-01 | 0.034 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.238416e-01 | 0.034 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.240860e-01 | 0.034 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.240860e-01 | 0.034 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 9.247769e-01 | 0.034 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.263805e-01 | 0.033 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 9.278156e-01 | 0.033 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 9.278156e-01 | 0.033 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.278156e-01 | 0.033 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.278156e-01 | 0.033 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.278156e-01 | 0.033 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.278156e-01 | 0.033 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 9.278156e-01 | 0.033 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.278156e-01 | 0.033 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.282209e-01 | 0.032 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.286710e-01 | 0.032 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.300213e-01 | 0.032 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.305903e-01 | 0.031 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.305903e-01 | 0.031 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.350473e-01 | 0.029 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 9.351008e-01 | 0.029 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.352843e-01 | 0.029 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.355268e-01 | 0.029 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.355268e-01 | 0.029 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.355268e-01 | 0.029 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.356167e-01 | 0.029 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 9.356167e-01 | 0.029 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.356167e-01 | 0.029 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.356167e-01 | 0.029 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.356167e-01 | 0.029 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 9.356167e-01 | 0.029 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.356167e-01 | 0.029 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.356167e-01 | 0.029 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.356167e-01 | 0.029 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.367704e-01 | 0.028 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.367704e-01 | 0.028 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.406299e-01 | 0.027 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.409280e-01 | 0.026 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.422663e-01 | 0.026 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.424259e-01 | 0.026 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.424259e-01 | 0.026 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 9.424259e-01 | 0.026 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.425751e-01 | 0.026 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 9.425751e-01 | 0.026 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.425751e-01 | 0.026 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.425751e-01 | 0.026 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.425751e-01 | 0.026 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.425751e-01 | 0.026 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.425751e-01 | 0.026 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.426446e-01 | 0.026 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.426446e-01 | 0.026 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.444990e-01 | 0.025 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.453565e-01 | 0.024 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.468306e-01 | 0.024 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.468306e-01 | 0.024 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.475980e-01 | 0.023 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.475980e-01 | 0.023 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.475980e-01 | 0.023 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.487818e-01 | 0.023 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.487818e-01 | 0.023 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.487818e-01 | 0.023 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.487818e-01 | 0.023 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.487818e-01 | 0.023 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.487818e-01 | 0.023 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.487818e-01 | 0.023 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.487818e-01 | 0.023 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.497312e-01 | 0.022 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.507350e-01 | 0.022 | 1 | 1 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.514606e-01 | 0.022 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 9.517971e-01 | 0.021 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 9.517971e-01 | 0.021 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.522430e-01 | 0.021 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.523250e-01 | 0.021 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.523250e-01 | 0.021 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.523250e-01 | 0.021 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.523250e-01 | 0.021 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.527029e-01 | 0.021 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.533056e-01 | 0.021 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.537775e-01 | 0.021 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.537775e-01 | 0.021 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.543180e-01 | 0.020 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.543180e-01 | 0.020 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.543180e-01 | 0.020 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 9.543180e-01 | 0.020 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.543180e-01 | 0.020 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.543742e-01 | 0.020 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.566428e-01 | 0.019 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.566428e-01 | 0.019 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.566428e-01 | 0.019 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.566428e-01 | 0.019 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.572996e-01 | 0.019 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.577642e-01 | 0.019 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.592561e-01 | 0.018 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.592561e-01 | 0.018 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.592561e-01 | 0.018 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.592561e-01 | 0.018 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 9.592561e-01 | 0.018 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.592561e-01 | 0.018 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.592561e-01 | 0.018 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.592561e-01 | 0.018 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 9.592561e-01 | 0.018 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.592561e-01 | 0.018 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.592561e-01 | 0.018 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.593776e-01 | 0.018 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.595582e-01 | 0.018 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.605845e-01 | 0.017 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.605845e-01 | 0.017 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.605845e-01 | 0.017 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.609074e-01 | 0.017 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.615356e-01 | 0.017 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.634576e-01 | 0.016 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.636606e-01 | 0.016 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.636606e-01 | 0.016 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.636606e-01 | 0.016 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.636606e-01 | 0.016 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.636606e-01 | 0.016 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.636606e-01 | 0.016 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.636606e-01 | 0.016 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.641618e-01 | 0.016 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.645767e-01 | 0.016 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.672316e-01 | 0.014 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.674608e-01 | 0.014 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.674608e-01 | 0.014 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.675087e-01 | 0.014 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.675892e-01 | 0.014 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 9.675892e-01 | 0.014 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.675892e-01 | 0.014 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.675892e-01 | 0.014 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.675892e-01 | 0.014 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.675892e-01 | 0.014 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.691607e-01 | 0.014 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.698179e-01 | 0.013 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.704504e-01 | 0.013 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.704504e-01 | 0.013 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.704504e-01 | 0.013 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.704504e-01 | 0.013 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.710934e-01 | 0.013 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.710934e-01 | 0.013 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.710934e-01 | 0.013 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.710934e-01 | 0.013 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.710934e-01 | 0.013 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.710934e-01 | 0.013 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.710934e-01 | 0.013 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.710934e-01 | 0.013 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.711558e-01 | 0.013 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.714784e-01 | 0.013 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.731741e-01 | 0.012 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.731938e-01 | 0.012 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 9.736259e-01 | 0.012 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.742188e-01 | 0.011 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 9.742188e-01 | 0.011 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.742188e-01 | 0.011 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.742188e-01 | 0.011 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 9.742188e-01 | 0.011 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.745314e-01 | 0.011 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.750224e-01 | 0.011 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.756545e-01 | 0.011 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.756545e-01 | 0.011 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.764513e-01 | 0.010 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 9.764793e-01 | 0.010 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.767423e-01 | 0.010 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.770065e-01 | 0.010 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.770065e-01 | 0.010 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.770065e-01 | 0.010 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.770065e-01 | 0.010 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.770065e-01 | 0.010 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.770065e-01 | 0.010 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.770065e-01 | 0.010 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.775752e-01 | 0.010 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.776237e-01 | 0.010 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.789763e-01 | 0.009 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.793187e-01 | 0.009 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.794929e-01 | 0.009 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.794929e-01 | 0.009 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.794929e-01 | 0.009 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.794929e-01 | 0.009 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.799667e-01 | 0.009 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.799667e-01 | 0.009 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.801442e-01 | 0.009 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.805995e-01 | 0.009 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.808626e-01 | 0.008 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.813643e-01 | 0.008 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.817106e-01 | 0.008 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.817106e-01 | 0.008 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.817106e-01 | 0.008 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.817106e-01 | 0.008 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.817106e-01 | 0.008 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.817106e-01 | 0.008 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.817106e-01 | 0.008 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.817106e-01 | 0.008 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.818352e-01 | 0.008 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.818352e-01 | 0.008 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.821376e-01 | 0.008 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.821376e-01 | 0.008 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.829538e-01 | 0.007 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.835341e-01 | 0.007 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.836533e-01 | 0.007 | 0 | 0 |
| Mucopolysaccharidoses | R-HSA-2206281 | 9.836885e-01 | 0.007 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.843915e-01 | 0.007 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.850927e-01 | 0.007 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.850927e-01 | 0.007 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.850927e-01 | 0.007 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.854527e-01 | 0.006 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.854527e-01 | 0.006 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.854527e-01 | 0.006 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.856282e-01 | 0.006 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 9.857816e-01 | 0.006 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.859932e-01 | 0.006 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 9.861654e-01 | 0.006 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.863234e-01 | 0.006 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.870261e-01 | 0.006 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.873064e-01 | 0.006 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.878145e-01 | 0.005 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.879147e-01 | 0.005 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.883804e-01 | 0.005 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.884295e-01 | 0.005 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.889113e-01 | 0.005 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.893916e-01 | 0.005 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.896811e-01 | 0.005 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.896811e-01 | 0.005 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.904608e-01 | 0.004 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.905230e-01 | 0.004 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.906471e-01 | 0.004 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.907974e-01 | 0.004 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.907974e-01 | 0.004 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.907974e-01 | 0.004 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.907974e-01 | 0.004 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.907974e-01 | 0.004 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.907974e-01 | 0.004 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.909136e-01 | 0.004 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.911597e-01 | 0.004 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.912907e-01 | 0.004 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.917776e-01 | 0.004 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.917776e-01 | 0.004 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.917776e-01 | 0.004 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.917930e-01 | 0.004 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.917930e-01 | 0.004 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.917930e-01 | 0.004 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.918201e-01 | 0.004 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.918654e-01 | 0.004 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.925610e-01 | 0.003 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.926809e-01 | 0.003 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.926809e-01 | 0.003 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.928540e-01 | 0.003 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.928540e-01 | 0.003 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.928540e-01 | 0.003 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.932163e-01 | 0.003 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.932713e-01 | 0.003 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.932713e-01 | 0.003 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.933074e-01 | 0.003 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.933236e-01 | 0.003 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.933795e-01 | 0.003 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.934728e-01 | 0.003 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.934728e-01 | 0.003 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.934728e-01 | 0.003 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.934728e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.934728e-01 | 0.003 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.935599e-01 | 0.003 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.939150e-01 | 0.003 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.939150e-01 | 0.003 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.939611e-01 | 0.003 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.941791e-01 | 0.003 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.943881e-01 | 0.002 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 9.944930e-01 | 0.002 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.944930e-01 | 0.002 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.944982e-01 | 0.002 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.944982e-01 | 0.002 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.945891e-01 | 0.002 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.948090e-01 | 0.002 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.948090e-01 | 0.002 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.948090e-01 | 0.002 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.949794e-01 | 0.002 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.950265e-01 | 0.002 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.950265e-01 | 0.002 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.950367e-01 | 0.002 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.951588e-01 | 0.002 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.953707e-01 | 0.002 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.953707e-01 | 0.002 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.953707e-01 | 0.002 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.953847e-01 | 0.002 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.955049e-01 | 0.002 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.956733e-01 | 0.002 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.958301e-01 | 0.002 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.958717e-01 | 0.002 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.959380e-01 | 0.002 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.961680e-01 | 0.002 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.961755e-01 | 0.002 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.963301e-01 | 0.002 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.963623e-01 | 0.002 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.964956e-01 | 0.002 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.966849e-01 | 0.001 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.967170e-01 | 0.001 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.967170e-01 | 0.001 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.967170e-01 | 0.001 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 9.967170e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.968493e-01 | 0.001 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.970060e-01 | 0.001 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.970598e-01 | 0.001 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.970724e-01 | 0.001 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.970724e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.972964e-01 | 0.001 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.973052e-01 | 0.001 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.973079e-01 | 0.001 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.975432e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.975432e-01 | 0.001 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.975446e-01 | 0.001 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.976239e-01 | 0.001 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.976719e-01 | 0.001 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.976719e-01 | 0.001 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.979240e-01 | 0.001 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.979240e-01 | 0.001 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.979240e-01 | 0.001 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.980264e-01 | 0.001 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.981487e-01 | 0.001 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.981487e-01 | 0.001 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.981487e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.982052e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.983492e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.983806e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.984125e-01 | 0.001 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.984212e-01 | 0.001 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.984400e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.984993e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.984993e-01 | 0.001 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.985279e-01 | 0.001 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.985279e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.985279e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.986821e-01 | 0.001 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.986821e-01 | 0.001 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.987954e-01 | 0.001 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.988114e-01 | 0.001 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.988114e-01 | 0.001 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.988295e-01 | 0.001 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.988295e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.988295e-01 | 0.001 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.988295e-01 | 0.001 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.988614e-01 | 0.000 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.988946e-01 | 0.000 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.989563e-01 | 0.000 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.989925e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.991287e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.991468e-01 | 0.000 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.991701e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.992600e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.992600e-01 | 0.000 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.992921e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.993402e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.993402e-01 | 0.000 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.993820e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.994116e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.994181e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.994251e-01 | 0.000 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.994535e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.994820e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.994820e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.995270e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.995322e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.995585e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.995789e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.995797e-01 | 0.000 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.995829e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.995829e-01 | 0.000 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.996181e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.996281e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.996281e-01 | 0.000 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.996331e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.996537e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.997043e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.997144e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.997364e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.997364e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.997471e-01 | 0.000 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.997511e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.997650e-01 | 0.000 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.997733e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.997760e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.997865e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.998185e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.998262e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.998334e-01 | 0.000 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.998676e-01 | 0.000 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 9.998709e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.998819e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.998879e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999061e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999216e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999330e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999363e-01 | 0.000 | 1 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999370e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.999454e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999471e-01 | 0.000 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.999471e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999525e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999542e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999582e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999595e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999625e-01 | 0.000 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.999625e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999687e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999701e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999741e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999766e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999788e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999812e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999813e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999832e-01 | 0.000 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.999840e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999859e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999873e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999892e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999924e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999924e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999925e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999940e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999947e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999966e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999975e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999980e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999984e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999990e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999993e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999994e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999995e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999996e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 1 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle, Mitotic | R-HSA-69278 | 2.739037e-10 | 9.562 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.407179e-10 | 9.468 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.167160e-09 | 8.933 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.154390e-07 | 6.938 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.691522e-07 | 6.772 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.764752e-07 | 6.558 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.113218e-07 | 6.507 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.938607e-07 | 6.532 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 5.143652e-07 | 6.289 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 5.143652e-07 | 6.289 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.722027e-07 | 6.172 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 7.989066e-07 | 6.098 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 9.709302e-07 | 6.013 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.619701e-06 | 5.791 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.757219e-06 | 5.425 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.386161e-06 | 5.358 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.440219e-06 | 5.353 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.211444e-06 | 5.086 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.015170e-05 | 4.993 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.505028e-05 | 4.822 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.523693e-05 | 4.817 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.089024e-05 | 4.680 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.290744e-05 | 4.640 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.744607e-05 | 4.562 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.024364e-05 | 4.519 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.765168e-05 | 4.424 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.077899e-05 | 4.390 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.579699e-05 | 4.253 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 5.686815e-05 | 4.245 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.069476e-05 | 4.217 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 6.047439e-05 | 4.218 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 6.401070e-05 | 4.194 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 6.762153e-05 | 4.170 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 6.818660e-05 | 4.166 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.903769e-05 | 4.102 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 9.921512e-05 | 4.003 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.162981e-04 | 3.934 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.191427e-04 | 3.924 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.241262e-04 | 3.906 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.328783e-04 | 3.877 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.474473e-04 | 3.831 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.470637e-04 | 3.832 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.474473e-04 | 3.831 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.567093e-04 | 3.805 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.811628e-04 | 3.742 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.919910e-04 | 3.717 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.724647e-04 | 3.565 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.386422e-04 | 3.470 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.386422e-04 | 3.470 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.492273e-04 | 3.457 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.576335e-04 | 3.447 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 4.009207e-04 | 3.397 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.093283e-04 | 3.388 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.711486e-04 | 3.327 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.711486e-04 | 3.327 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.720590e-04 | 3.326 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 5.186899e-04 | 3.285 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.503080e-04 | 3.259 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.788781e-04 | 3.237 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.876963e-04 | 3.231 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 5.762259e-04 | 3.239 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 6.338944e-04 | 3.198 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.338944e-04 | 3.198 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 6.338944e-04 | 3.198 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.234123e-04 | 3.205 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 6.434741e-04 | 3.191 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 7.064039e-04 | 3.151 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.793524e-04 | 3.108 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.793524e-04 | 3.108 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.853064e-04 | 3.105 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.853064e-04 | 3.105 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 9.033551e-04 | 3.044 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.929944e-04 | 3.049 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 8.794462e-04 | 3.056 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 9.206687e-04 | 3.036 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 9.386472e-04 | 3.027 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 9.719428e-04 | 3.012 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 9.992692e-04 | 3.000 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 9.961072e-04 | 3.002 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.088191e-03 | 2.963 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.070309e-03 | 2.970 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.116720e-03 | 2.952 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.148912e-03 | 2.940 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.148912e-03 | 2.940 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.236130e-03 | 2.908 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.236130e-03 | 2.908 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.367383e-03 | 2.864 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.393002e-03 | 2.856 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.472389e-03 | 2.832 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.684935e-03 | 2.773 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.708496e-03 | 2.767 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.784631e-03 | 2.748 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.803046e-03 | 2.744 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.014977e-03 | 2.696 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.014977e-03 | 2.696 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.014977e-03 | 2.696 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.014977e-03 | 2.696 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.020286e-03 | 2.695 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.054604e-03 | 2.687 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.199112e-03 | 2.658 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.429404e-03 | 2.615 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.449476e-03 | 2.611 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.449476e-03 | 2.611 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.529055e-03 | 2.597 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.579170e-03 | 2.589 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.815100e-03 | 2.551 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.079574e-03 | 2.512 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.224116e-03 | 2.492 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.224116e-03 | 2.492 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.224116e-03 | 2.492 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.356045e-03 | 2.474 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.399410e-03 | 2.469 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.524354e-03 | 2.453 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.524354e-03 | 2.453 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 4.034595e-03 | 2.394 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.034595e-03 | 2.394 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.951477e-03 | 2.403 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.058634e-03 | 2.392 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.361493e-03 | 2.360 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.436982e-03 | 2.353 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.509071e-03 | 2.346 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.524927e-03 | 2.344 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.619173e-03 | 2.335 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.680564e-03 | 2.330 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.680564e-03 | 2.330 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.743134e-03 | 2.324 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.332578e-03 | 2.273 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 5.034841e-03 | 2.298 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.216393e-03 | 2.283 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.032514e-03 | 2.298 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 5.324245e-03 | 2.274 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.510150e-03 | 2.259 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 5.735247e-03 | 2.241 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 5.735247e-03 | 2.241 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.838410e-03 | 2.234 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.449005e-03 | 2.191 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.555042e-03 | 2.183 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 6.686891e-03 | 2.175 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 6.686891e-03 | 2.175 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.032370e-03 | 2.153 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 7.067877e-03 | 2.151 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 7.121879e-03 | 2.147 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.296816e-03 | 2.137 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 7.931277e-03 | 2.101 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 7.508098e-03 | 2.124 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 8.073206e-03 | 2.093 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.073206e-03 | 2.093 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 8.382839e-03 | 2.077 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.391221e-03 | 2.076 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 8.403542e-03 | 2.076 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.414900e-03 | 2.075 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 9.111363e-03 | 2.040 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 9.215123e-03 | 2.035 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 9.405028e-03 | 2.027 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 9.729384e-03 | 2.012 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 9.729384e-03 | 2.012 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 9.821506e-03 | 2.008 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.026033e-02 | 1.989 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.048337e-02 | 1.979 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.048337e-02 | 1.979 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.080046e-02 | 1.967 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.165485e-02 | 1.933 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.086684e-02 | 1.964 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.081254e-02 | 1.966 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.198032e-02 | 1.922 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.198032e-02 | 1.922 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.198032e-02 | 1.922 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.198032e-02 | 1.922 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.198032e-02 | 1.922 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.198032e-02 | 1.922 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.251868e-02 | 1.902 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.251868e-02 | 1.902 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.258967e-02 | 1.900 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.292446e-02 | 1.889 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.298589e-02 | 1.887 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.313211e-02 | 1.882 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.368411e-02 | 1.864 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.468828e-02 | 1.833 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.504283e-02 | 1.823 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.504283e-02 | 1.823 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.429717e-02 | 1.845 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.513261e-02 | 1.820 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.326248e-02 | 1.877 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.335619e-02 | 1.874 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.429717e-02 | 1.845 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.515186e-02 | 1.820 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.500269e-02 | 1.824 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.684368e-02 | 1.774 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.778244e-02 | 1.750 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.852412e-02 | 1.732 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.874254e-02 | 1.727 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.898415e-02 | 1.722 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.002105e-02 | 1.699 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.006126e-02 | 1.698 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.033166e-02 | 1.692 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.041720e-02 | 1.690 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.041720e-02 | 1.690 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.085002e-02 | 1.681 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.109514e-02 | 1.676 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.109514e-02 | 1.676 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.109514e-02 | 1.676 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.109514e-02 | 1.676 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.300188e-02 | 1.638 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.303954e-02 | 1.638 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.341571e-02 | 1.630 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.405295e-02 | 1.619 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.511013e-02 | 1.600 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.554727e-02 | 1.593 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.554727e-02 | 1.593 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.555229e-02 | 1.593 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.555229e-02 | 1.593 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.872487e-02 | 1.542 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.710540e-02 | 1.567 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.710540e-02 | 1.567 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.050941e-02 | 1.516 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.922413e-02 | 1.534 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.710540e-02 | 1.567 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.055936e-02 | 1.515 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 3.055936e-02 | 1.515 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.102040e-02 | 1.508 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.164158e-02 | 1.500 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.278714e-02 | 1.484 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.477042e-02 | 1.459 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.584213e-02 | 1.446 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.598109e-02 | 1.444 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.598109e-02 | 1.444 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.626487e-02 | 1.441 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.646976e-02 | 1.438 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.307755e-02 | 1.366 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.307755e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.307755e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.307755e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.307755e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.307755e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.307755e-02 | 1.366 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.307755e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.307755e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.307755e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.307755e-02 | 1.366 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.855853e-02 | 1.414 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.855853e-02 | 1.414 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.377109e-02 | 1.359 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.377109e-02 | 1.359 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.377109e-02 | 1.359 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.232691e-02 | 1.373 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.064655e-02 | 1.391 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.377109e-02 | 1.359 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.412833e-02 | 1.355 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.974115e-02 | 1.401 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.917810e-02 | 1.407 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.364239e-02 | 1.360 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.960804e-02 | 1.402 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.198443e-02 | 1.377 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.198443e-02 | 1.377 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.371833e-02 | 1.359 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.687147e-02 | 1.433 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.403855e-02 | 1.356 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 4.371833e-02 | 1.359 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.634975e-02 | 1.334 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.640901e-02 | 1.333 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.832960e-02 | 1.316 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.861233e-02 | 1.313 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 4.871899e-02 | 1.312 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 4.987906e-02 | 1.302 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.987906e-02 | 1.302 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.987906e-02 | 1.302 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.998333e-02 | 1.301 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.243185e-02 | 1.280 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.243185e-02 | 1.280 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 5.243185e-02 | 1.280 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.284517e-02 | 1.277 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.414867e-02 | 1.266 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 5.415553e-02 | 1.266 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.415553e-02 | 1.266 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.614512e-02 | 1.251 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.640834e-02 | 1.249 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 5.648213e-02 | 1.248 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 5.656159e-02 | 1.247 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.945808e-02 | 1.226 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 5.995626e-02 | 1.222 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.106888e-02 | 1.214 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 6.146488e-02 | 1.211 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 6.146488e-02 | 1.211 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 6.385295e-02 | 1.195 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 6.262440e-02 | 1.203 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.262440e-02 | 1.203 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.262440e-02 | 1.203 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 7.671492e-02 | 1.115 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 7.232438e-02 | 1.141 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 7.232438e-02 | 1.141 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.304244e-02 | 1.136 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 7.028447e-02 | 1.153 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 7.302145e-02 | 1.137 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 7.302145e-02 | 1.137 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 6.161679e-02 | 1.210 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 6.675905e-02 | 1.175 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.675905e-02 | 1.175 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.264082e-02 | 1.139 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 7.232438e-02 | 1.141 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.671492e-02 | 1.115 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 7.303438e-02 | 1.136 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 7.028447e-02 | 1.153 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.691032e-02 | 1.114 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 6.764235e-02 | 1.170 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.919209e-02 | 1.160 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.708972e-02 | 1.173 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.400509e-02 | 1.131 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.245323e-02 | 1.204 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 7.232438e-02 | 1.141 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.593019e-02 | 1.181 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.195506e-02 | 1.208 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.708972e-02 | 1.173 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.691032e-02 | 1.114 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 6.496847e-02 | 1.187 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.796649e-02 | 1.108 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 7.847598e-02 | 1.105 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.926090e-02 | 1.101 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 7.974589e-02 | 1.098 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.178281e-02 | 1.087 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 8.221266e-02 | 1.085 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 8.351633e-02 | 1.078 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 8.351633e-02 | 1.078 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.470193e-02 | 1.072 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 8.610199e-02 | 1.065 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 8.726125e-02 | 1.059 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 8.726125e-02 | 1.059 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 8.726125e-02 | 1.059 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 8.726125e-02 | 1.059 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 8.726125e-02 | 1.059 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 8.726125e-02 | 1.059 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 8.726125e-02 | 1.059 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.833630e-02 | 1.054 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 8.865470e-02 | 1.052 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 9.205800e-02 | 1.036 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 9.205800e-02 | 1.036 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 9.205800e-02 | 1.036 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 9.205800e-02 | 1.036 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 9.266167e-02 | 1.033 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 9.468542e-02 | 1.024 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 9.520031e-02 | 1.021 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 9.550111e-02 | 1.020 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 9.550111e-02 | 1.020 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 9.550111e-02 | 1.020 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.901182e-02 | 1.004 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.003684e-01 | 0.998 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.004532e-01 | 0.998 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.011928e-01 | 0.995 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.024704e-01 | 0.989 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.031338e-01 | 0.987 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.037052e-01 | 0.984 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.037093e-01 | 0.984 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.037093e-01 | 0.984 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.049230e-01 | 0.979 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.060897e-01 | 0.974 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.082435e-01 | 0.966 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.127619e-01 | 0.948 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.127619e-01 | 0.948 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.127619e-01 | 0.948 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.398830e-01 | 0.854 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.398830e-01 | 0.854 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.085519e-01 | 0.964 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.085519e-01 | 0.964 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.085519e-01 | 0.964 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.260887e-01 | 0.899 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.260887e-01 | 0.899 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.445576e-01 | 0.840 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 1.445576e-01 | 0.840 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 1.445576e-01 | 0.840 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.445576e-01 | 0.840 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.445576e-01 | 0.840 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.445576e-01 | 0.840 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.445576e-01 | 0.840 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.445576e-01 | 0.840 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 1.217035e-01 | 0.915 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.230388e-01 | 0.910 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.230388e-01 | 0.910 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.439950e-01 | 0.842 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.400499e-01 | 0.854 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.364307e-01 | 0.865 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.379406e-01 | 0.860 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.379406e-01 | 0.860 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.445576e-01 | 0.840 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.358376e-01 | 0.867 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.445576e-01 | 0.840 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.112081e-01 | 0.954 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.445576e-01 | 0.840 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.325768e-01 | 0.878 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 1.398830e-01 | 0.854 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.364307e-01 | 0.865 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.248380e-01 | 0.904 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.120943e-01 | 0.950 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.398830e-01 | 0.854 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.236955e-01 | 0.908 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.183602e-01 | 0.927 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.398830e-01 | 0.854 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.400499e-01 | 0.854 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.439950e-01 | 0.842 | 0 | 0 |
| Metallothioneins bind metals | R-HSA-5661231 | 1.445576e-01 | 0.840 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.191424e-01 | 0.924 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.131417e-01 | 0.946 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.101129e-01 | 0.958 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.101129e-01 | 0.958 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.101129e-01 | 0.958 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.101129e-01 | 0.958 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.101129e-01 | 0.958 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.462582e-01 | 0.835 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.474296e-01 | 0.831 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.476377e-01 | 0.831 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.476377e-01 | 0.831 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.489455e-01 | 0.827 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 1.505989e-01 | 0.822 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.505989e-01 | 0.822 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.507978e-01 | 0.822 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.507978e-01 | 0.822 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 1.507978e-01 | 0.822 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.507978e-01 | 0.822 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.507978e-01 | 0.822 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 1.507978e-01 | 0.822 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.543275e-01 | 0.812 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.543275e-01 | 0.812 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.555609e-01 | 0.808 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.572410e-01 | 0.803 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.576468e-01 | 0.802 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.581081e-01 | 0.801 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.581081e-01 | 0.801 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.607607e-01 | 0.794 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.609243e-01 | 0.793 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.616422e-01 | 0.791 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.638463e-01 | 0.786 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.638463e-01 | 0.786 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.638463e-01 | 0.786 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.659260e-01 | 0.780 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 1.659383e-01 | 0.780 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.659383e-01 | 0.780 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.659383e-01 | 0.780 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.659383e-01 | 0.780 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.664581e-01 | 0.779 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 1.682135e-01 | 0.774 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 1.682135e-01 | 0.774 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 1.682135e-01 | 0.774 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.705020e-01 | 0.768 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.711270e-01 | 0.767 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.174477e-01 | 0.663 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 2.174477e-01 | 0.663 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.174477e-01 | 0.663 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.174477e-01 | 0.663 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.174477e-01 | 0.663 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.973970e-01 | 0.705 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.973970e-01 | 0.705 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.973970e-01 | 0.705 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.973970e-01 | 0.705 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.973970e-01 | 0.705 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.973970e-01 | 0.705 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.271255e-01 | 0.644 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.271255e-01 | 0.644 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 1.838435e-01 | 0.736 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.571340e-01 | 0.590 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.571340e-01 | 0.590 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.571340e-01 | 0.590 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.044398e-01 | 0.689 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.044398e-01 | 0.689 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.255295e-01 | 0.647 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.255295e-01 | 0.647 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.818048e-01 | 0.740 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.470107e-01 | 0.607 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.749018e-01 | 0.757 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.320461e-01 | 0.634 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.465419e-01 | 0.608 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.282553e-01 | 0.642 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.839516e-01 | 0.735 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.353683e-01 | 0.628 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.353683e-01 | 0.628 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.749018e-01 | 0.757 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.320461e-01 | 0.634 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.749018e-01 | 0.757 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.902886e-01 | 0.721 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.494988e-01 | 0.603 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.749018e-01 | 0.757 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.026685e-01 | 0.693 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.028009e-01 | 0.693 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.790402e-01 | 0.747 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 1.973970e-01 | 0.705 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.818048e-01 | 0.740 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.324732e-01 | 0.634 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.494988e-01 | 0.603 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.496566e-01 | 0.603 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.255295e-01 | 0.647 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.838435e-01 | 0.736 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.571340e-01 | 0.590 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.316060e-01 | 0.635 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.414195e-01 | 0.617 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.153312e-01 | 0.667 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.837432e-01 | 0.736 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.422781e-01 | 0.616 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.076097e-01 | 0.683 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.470107e-01 | 0.607 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.026685e-01 | 0.693 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.282553e-01 | 0.642 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.149113e-01 | 0.668 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.197134e-01 | 0.658 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.169422e-01 | 0.664 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.236050e-01 | 0.651 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.571340e-01 | 0.590 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.571340e-01 | 0.590 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.818048e-01 | 0.740 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.771999e-01 | 0.752 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.548018e-01 | 0.594 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.749018e-01 | 0.757 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.749989e-01 | 0.757 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.289404e-01 | 0.640 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.289404e-01 | 0.640 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.125140e-01 | 0.673 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.571340e-01 | 0.590 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.889337e-01 | 0.724 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.347124e-01 | 0.629 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.044398e-01 | 0.689 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.149113e-01 | 0.668 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.324732e-01 | 0.634 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.986175e-01 | 0.702 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.749018e-01 | 0.757 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.746297e-01 | 0.758 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.981467e-01 | 0.703 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.571340e-01 | 0.590 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.818048e-01 | 0.740 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.571340e-01 | 0.590 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.422781e-01 | 0.616 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.571340e-01 | 0.590 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.818048e-01 | 0.740 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.128950e-01 | 0.672 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 2.571340e-01 | 0.590 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.095335e-01 | 0.679 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.086154e-01 | 0.681 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.078568e-01 | 0.682 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.136910e-01 | 0.670 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.617180e-01 | 0.582 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 2.788703e-01 | 0.555 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 2.788703e-01 | 0.555 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.788703e-01 | 0.555 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.788703e-01 | 0.555 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 2.788703e-01 | 0.555 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.354751e-01 | 0.474 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 3.876399e-01 | 0.412 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.876399e-01 | 0.412 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 3.876399e-01 | 0.412 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 3.876399e-01 | 0.412 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 3.876399e-01 | 0.412 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.871955e-01 | 0.542 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.871955e-01 | 0.542 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 3.171172e-01 | 0.499 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.171172e-01 | 0.499 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.171172e-01 | 0.499 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.171172e-01 | 0.499 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.171172e-01 | 0.499 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 4.357127e-01 | 0.361 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.357127e-01 | 0.361 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 4.357127e-01 | 0.361 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 4.357127e-01 | 0.361 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.687865e-01 | 0.571 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.687865e-01 | 0.571 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.467359e-01 | 0.460 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.907656e-01 | 0.536 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 2.907656e-01 | 0.536 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.128620e-01 | 0.505 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.128620e-01 | 0.505 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.128620e-01 | 0.505 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.759150e-01 | 0.425 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.800141e-01 | 0.319 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 4.800141e-01 | 0.319 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 4.800141e-01 | 0.319 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 4.800141e-01 | 0.319 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 4.800141e-01 | 0.319 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 4.800141e-01 | 0.319 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.851534e-01 | 0.545 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.851534e-01 | 0.545 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.851534e-01 | 0.545 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.349960e-01 | 0.475 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.032559e-01 | 0.518 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.032559e-01 | 0.518 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.032559e-01 | 0.518 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.045410e-01 | 0.393 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.771021e-01 | 0.557 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.771021e-01 | 0.557 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.570937e-01 | 0.447 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.570937e-01 | 0.447 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.570937e-01 | 0.447 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.214783e-01 | 0.493 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.214783e-01 | 0.493 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.790872e-01 | 0.421 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 3.790872e-01 | 0.421 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.790872e-01 | 0.421 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.325212e-01 | 0.364 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.325212e-01 | 0.364 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.208400e-01 | 0.283 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 5.208400e-01 | 0.283 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.208400e-01 | 0.283 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.208400e-01 | 0.283 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.208400e-01 | 0.283 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.208400e-01 | 0.283 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 5.208400e-01 | 0.283 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.719779e-01 | 0.565 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.009146e-01 | 0.397 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.597805e-01 | 0.337 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 4.597805e-01 | 0.337 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 4.597805e-01 | 0.337 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 4.597805e-01 | 0.337 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 4.597805e-01 | 0.337 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 4.225197e-01 | 0.374 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 4.225197e-01 | 0.374 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.946873e-01 | 0.404 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.731511e-01 | 0.564 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.128685e-01 | 0.384 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 4.862598e-01 | 0.313 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.309288e-01 | 0.366 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.689181e-01 | 0.433 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.119135e-01 | 0.291 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.855238e-01 | 0.314 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.276299e-01 | 0.369 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 4.004179e-01 | 0.397 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.529320e-01 | 0.344 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.057883e-01 | 0.296 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.057883e-01 | 0.296 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 5.057883e-01 | 0.296 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.256299e-01 | 0.279 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.256299e-01 | 0.279 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.946873e-01 | 0.404 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.672180e-01 | 0.573 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.960362e-01 | 0.529 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.771021e-01 | 0.557 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.759150e-01 | 0.425 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.400922e-01 | 0.468 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.783015e-01 | 0.320 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.871955e-01 | 0.542 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 4.438522e-01 | 0.353 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.537627e-01 | 0.343 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.268757e-01 | 0.370 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.907656e-01 | 0.536 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.719090e-01 | 0.566 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.029717e-01 | 0.395 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.871955e-01 | 0.542 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 3.467359e-01 | 0.460 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.325212e-01 | 0.364 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 4.009146e-01 | 0.397 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.400922e-01 | 0.468 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.923713e-01 | 0.534 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.862598e-01 | 0.313 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.183771e-01 | 0.285 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.309288e-01 | 0.366 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.361054e-01 | 0.474 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.357360e-01 | 0.474 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 4.800141e-01 | 0.319 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.045410e-01 | 0.393 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.959261e-01 | 0.529 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.438522e-01 | 0.353 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.516924e-01 | 0.454 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.149135e-01 | 0.288 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 2.672180e-01 | 0.573 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 3.946873e-01 | 0.404 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.541969e-01 | 0.343 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.467359e-01 | 0.460 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.672180e-01 | 0.573 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 4.438522e-01 | 0.353 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.446691e-01 | 0.463 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.446691e-01 | 0.463 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.276299e-01 | 0.369 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.171172e-01 | 0.499 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.357127e-01 | 0.361 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.357127e-01 | 0.361 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 4.357127e-01 | 0.361 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 2.687865e-01 | 0.571 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.687865e-01 | 0.571 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 3.467359e-01 | 0.460 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.648668e-01 | 0.333 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.648668e-01 | 0.333 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.309288e-01 | 0.366 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.810980e-01 | 0.419 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.670687e-01 | 0.435 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.689181e-01 | 0.433 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.057883e-01 | 0.296 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.871955e-01 | 0.542 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.672180e-01 | 0.573 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 3.876399e-01 | 0.412 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.687865e-01 | 0.571 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.672180e-01 | 0.573 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 4.800141e-01 | 0.319 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 4.325212e-01 | 0.364 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 4.555390e-01 | 0.341 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.907656e-01 | 0.536 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.648668e-01 | 0.333 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.672180e-01 | 0.573 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.694798e-01 | 0.432 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 4.862598e-01 | 0.313 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.771021e-01 | 0.557 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 2.788703e-01 | 0.555 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 2.788703e-01 | 0.555 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.788703e-01 | 0.555 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.354751e-01 | 0.474 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.467359e-01 | 0.460 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.467359e-01 | 0.460 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.467359e-01 | 0.460 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 3.759150e-01 | 0.425 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 4.800141e-01 | 0.319 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.771021e-01 | 0.557 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 4.597805e-01 | 0.337 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 4.597805e-01 | 0.337 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.597805e-01 | 0.337 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 4.862598e-01 | 0.313 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.518082e-01 | 0.454 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 5.256299e-01 | 0.279 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.130088e-01 | 0.290 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.223757e-01 | 0.282 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.737183e-01 | 0.563 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.299037e-01 | 0.367 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.488361e-01 | 0.348 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 4.225197e-01 | 0.374 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.926626e-01 | 0.534 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.567710e-01 | 0.448 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.529632e-01 | 0.452 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.871955e-01 | 0.542 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.871955e-01 | 0.542 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.357127e-01 | 0.361 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.325212e-01 | 0.364 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 3.630362e-01 | 0.440 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 4.855238e-01 | 0.314 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.110232e-01 | 0.292 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.796483e-01 | 0.319 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.771021e-01 | 0.557 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 3.876399e-01 | 0.412 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.357127e-01 | 0.361 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.759150e-01 | 0.425 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 4.800141e-01 | 0.319 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.978664e-01 | 0.303 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.825485e-01 | 0.316 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.516924e-01 | 0.454 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.670687e-01 | 0.435 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.009703e-01 | 0.397 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.720378e-01 | 0.429 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 4.855238e-01 | 0.314 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.072500e-01 | 0.390 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.436052e-01 | 0.353 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.514575e-01 | 0.345 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.741300e-01 | 0.324 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 3.876399e-01 | 0.412 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 2.871955e-01 | 0.542 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.467359e-01 | 0.460 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.128620e-01 | 0.505 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.800141e-01 | 0.319 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.009146e-01 | 0.397 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.119135e-01 | 0.291 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.024824e-01 | 0.299 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.880236e-01 | 0.411 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.244649e-01 | 0.372 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.349960e-01 | 0.475 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.560516e-01 | 0.448 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.683801e-01 | 0.571 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 3.349960e-01 | 0.475 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.183771e-01 | 0.285 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.051901e-01 | 0.297 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.946873e-01 | 0.404 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.768903e-01 | 0.558 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.896256e-01 | 0.409 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 3.354751e-01 | 0.474 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.349960e-01 | 0.475 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 4.225197e-01 | 0.374 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 5.256299e-01 | 0.279 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.128620e-01 | 0.505 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.119135e-01 | 0.291 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.739880e-01 | 0.562 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.100697e-01 | 0.509 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 2.871955e-01 | 0.542 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 4.357127e-01 | 0.361 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 4.045410e-01 | 0.393 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.581027e-01 | 0.446 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.183771e-01 | 0.285 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.851534e-01 | 0.545 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 2.851534e-01 | 0.545 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 3.759150e-01 | 0.425 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.946873e-01 | 0.404 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 5.075223e-01 | 0.295 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.256299e-01 | 0.279 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.208400e-01 | 0.283 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.208400e-01 | 0.283 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.597805e-01 | 0.337 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.537627e-01 | 0.343 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.087417e-01 | 0.294 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.241880e-01 | 0.489 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 4.862598e-01 | 0.313 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.171172e-01 | 0.499 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.648668e-01 | 0.333 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.177128e-01 | 0.379 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.171172e-01 | 0.499 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 4.800141e-01 | 0.319 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.208400e-01 | 0.283 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.852814e-01 | 0.545 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.225197e-01 | 0.374 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.035272e-01 | 0.518 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.078507e-01 | 0.294 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.438522e-01 | 0.353 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.438522e-01 | 0.353 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 3.759150e-01 | 0.425 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.771021e-01 | 0.557 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.057883e-01 | 0.296 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.241880e-01 | 0.489 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.119135e-01 | 0.291 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.871955e-01 | 0.542 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 3.264833e-01 | 0.486 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.597805e-01 | 0.337 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 5.183771e-01 | 0.285 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.397751e-01 | 0.469 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.334307e-01 | 0.273 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.346577e-01 | 0.272 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.351207e-01 | 0.272 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 5.351207e-01 | 0.272 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 5.351207e-01 | 0.272 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 5.351207e-01 | 0.272 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.367081e-01 | 0.270 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.367081e-01 | 0.270 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 5.367081e-01 | 0.270 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 5.367081e-01 | 0.270 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.367081e-01 | 0.270 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 5.367081e-01 | 0.270 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.388143e-01 | 0.269 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.427037e-01 | 0.265 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 5.427037e-01 | 0.265 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.445300e-01 | 0.264 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.450229e-01 | 0.264 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.450229e-01 | 0.264 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 5.515677e-01 | 0.258 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.572276e-01 | 0.254 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.584627e-01 | 0.253 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 5.584627e-01 | 0.253 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 5.584627e-01 | 0.253 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.584627e-01 | 0.253 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 5.584627e-01 | 0.253 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 5.584627e-01 | 0.253 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 5.584627e-01 | 0.253 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 5.584627e-01 | 0.253 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.584627e-01 | 0.253 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.584627e-01 | 0.253 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 5.584627e-01 | 0.253 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.584627e-01 | 0.253 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 5.584627e-01 | 0.253 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 5.584627e-01 | 0.253 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.590899e-01 | 0.253 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 5.606204e-01 | 0.251 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.606204e-01 | 0.251 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 5.606204e-01 | 0.251 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 5.606204e-01 | 0.251 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 5.606204e-01 | 0.251 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.606204e-01 | 0.251 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.606204e-01 | 0.251 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 5.606204e-01 | 0.251 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.639093e-01 | 0.249 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.639093e-01 | 0.249 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.639453e-01 | 0.249 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.648589e-01 | 0.248 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 5.677016e-01 | 0.246 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.789175e-01 | 0.237 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.789175e-01 | 0.237 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.826903e-01 | 0.235 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 5.835084e-01 | 0.234 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.836360e-01 | 0.234 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.836360e-01 | 0.234 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.836360e-01 | 0.234 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.836360e-01 | 0.234 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.836360e-01 | 0.234 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.855666e-01 | 0.232 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.855666e-01 | 0.232 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.860925e-01 | 0.232 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 5.891486e-01 | 0.230 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.930825e-01 | 0.227 | 0 | 0 |
| RSK activation | R-HSA-444257 | 5.931335e-01 | 0.227 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 5.931335e-01 | 0.227 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 5.931335e-01 | 0.227 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 5.931335e-01 | 0.227 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 5.931335e-01 | 0.227 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 5.931335e-01 | 0.227 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 5.931335e-01 | 0.227 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 5.931335e-01 | 0.227 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 5.931335e-01 | 0.227 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 5.931335e-01 | 0.227 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 5.931335e-01 | 0.227 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 5.931335e-01 | 0.227 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 5.931335e-01 | 0.227 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 5.931335e-01 | 0.227 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 5.931335e-01 | 0.227 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 5.931335e-01 | 0.227 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 5.931335e-01 | 0.227 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 5.931335e-01 | 0.227 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 5.931335e-01 | 0.227 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 5.931335e-01 | 0.227 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 5.934209e-01 | 0.227 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.954281e-01 | 0.225 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.961728e-01 | 0.225 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.984263e-01 | 0.223 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.989754e-01 | 0.223 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 5.989754e-01 | 0.223 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.993603e-01 | 0.222 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.993603e-01 | 0.222 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 5.993603e-01 | 0.222 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.993603e-01 | 0.222 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.003102e-01 | 0.222 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.003102e-01 | 0.222 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 6.057483e-01 | 0.218 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.057483e-01 | 0.218 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.057483e-01 | 0.218 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.057483e-01 | 0.218 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.057483e-01 | 0.218 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.057483e-01 | 0.218 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.057483e-01 | 0.218 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.057483e-01 | 0.218 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.108153e-01 | 0.214 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.128912e-01 | 0.213 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.129483e-01 | 0.213 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.177271e-01 | 0.209 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.177271e-01 | 0.209 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.177271e-01 | 0.209 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.177271e-01 | 0.209 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.177271e-01 | 0.209 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.177271e-01 | 0.209 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.236944e-01 | 0.205 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 6.250837e-01 | 0.204 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.250837e-01 | 0.204 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.250837e-01 | 0.204 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.250837e-01 | 0.204 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 6.250837e-01 | 0.204 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 6.250837e-01 | 0.204 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.250837e-01 | 0.204 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 6.250837e-01 | 0.204 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.250837e-01 | 0.204 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.250837e-01 | 0.204 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.250837e-01 | 0.204 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 6.250837e-01 | 0.204 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 6.250837e-01 | 0.204 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 6.250837e-01 | 0.204 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.269573e-01 | 0.203 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.269573e-01 | 0.203 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.269573e-01 | 0.203 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 6.269573e-01 | 0.203 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.288499e-01 | 0.201 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.346217e-01 | 0.197 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.346217e-01 | 0.197 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.369984e-01 | 0.196 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.377467e-01 | 0.195 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.388538e-01 | 0.195 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 6.432413e-01 | 0.192 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.432413e-01 | 0.192 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.460577e-01 | 0.190 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.460577e-01 | 0.190 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 6.465020e-01 | 0.189 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.472685e-01 | 0.189 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.472685e-01 | 0.189 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.472685e-01 | 0.189 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.492135e-01 | 0.188 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 6.509887e-01 | 0.186 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.509887e-01 | 0.186 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 6.518344e-01 | 0.186 | 1 | 1 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.545267e-01 | 0.184 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.545267e-01 | 0.184 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.545267e-01 | 0.184 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 6.545267e-01 | 0.184 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 6.545267e-01 | 0.184 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.545267e-01 | 0.184 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.545267e-01 | 0.184 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 6.545267e-01 | 0.184 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 6.545267e-01 | 0.184 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 6.545267e-01 | 0.184 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 6.561043e-01 | 0.183 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.572606e-01 | 0.182 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.572606e-01 | 0.182 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.636634e-01 | 0.178 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 6.641373e-01 | 0.178 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.642463e-01 | 0.178 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.666920e-01 | 0.176 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.666920e-01 | 0.176 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.666920e-01 | 0.176 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 6.666920e-01 | 0.176 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.666920e-01 | 0.176 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.666920e-01 | 0.176 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.668250e-01 | 0.176 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.680927e-01 | 0.175 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 6.763665e-01 | 0.170 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.763665e-01 | 0.170 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 6.763665e-01 | 0.170 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.763665e-01 | 0.170 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.813760e-01 | 0.167 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 6.816590e-01 | 0.166 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 6.816590e-01 | 0.166 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 6.816590e-01 | 0.166 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 6.816590e-01 | 0.166 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 6.816590e-01 | 0.166 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 6.816590e-01 | 0.166 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 6.816590e-01 | 0.166 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 6.816590e-01 | 0.166 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 6.816590e-01 | 0.166 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 6.816590e-01 | 0.166 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 6.816590e-01 | 0.166 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 6.816590e-01 | 0.166 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 6.816590e-01 | 0.166 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 6.821301e-01 | 0.166 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 6.821301e-01 | 0.166 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 6.841678e-01 | 0.165 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 6.852420e-01 | 0.164 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.852420e-01 | 0.164 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.852420e-01 | 0.164 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.881918e-01 | 0.162 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.969052e-01 | 0.157 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 6.970510e-01 | 0.157 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 6.983432e-01 | 0.156 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.997203e-01 | 0.155 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.997203e-01 | 0.155 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.997203e-01 | 0.155 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.005881e-01 | 0.155 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.029358e-01 | 0.153 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.029358e-01 | 0.153 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 7.029358e-01 | 0.153 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.029358e-01 | 0.153 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.044273e-01 | 0.152 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.066620e-01 | 0.151 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 7.066620e-01 | 0.151 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.066620e-01 | 0.151 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 7.066620e-01 | 0.151 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.066620e-01 | 0.151 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.066620e-01 | 0.151 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.066620e-01 | 0.151 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 7.095529e-01 | 0.149 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.109503e-01 | 0.148 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.111537e-01 | 0.148 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.175991e-01 | 0.144 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.197935e-01 | 0.143 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.197935e-01 | 0.143 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.197935e-01 | 0.143 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.197935e-01 | 0.143 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 7.197935e-01 | 0.143 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.197935e-01 | 0.143 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 7.216742e-01 | 0.142 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 7.248802e-01 | 0.140 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.297026e-01 | 0.137 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 7.297026e-01 | 0.137 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 7.297026e-01 | 0.137 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 7.297026e-01 | 0.137 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.297026e-01 | 0.137 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.297026e-01 | 0.137 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.297026e-01 | 0.137 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.297026e-01 | 0.137 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.297026e-01 | 0.137 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.297026e-01 | 0.137 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.297026e-01 | 0.137 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.297026e-01 | 0.137 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 7.297026e-01 | 0.137 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.297026e-01 | 0.137 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.297026e-01 | 0.137 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.321611e-01 | 0.135 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.334164e-01 | 0.135 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.334164e-01 | 0.135 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.335841e-01 | 0.135 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 7.347300e-01 | 0.134 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.347300e-01 | 0.134 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.347300e-01 | 0.134 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.352165e-01 | 0.134 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.358373e-01 | 0.133 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.358373e-01 | 0.133 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.358373e-01 | 0.133 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.358373e-01 | 0.133 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 7.358373e-01 | 0.133 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 7.380912e-01 | 0.132 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.380912e-01 | 0.132 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.380912e-01 | 0.132 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.380912e-01 | 0.132 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.380912e-01 | 0.132 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.428473e-01 | 0.129 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.446091e-01 | 0.128 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.447819e-01 | 0.128 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 7.507941e-01 | 0.124 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 7.509347e-01 | 0.124 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 7.509347e-01 | 0.124 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.509347e-01 | 0.124 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.509347e-01 | 0.124 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.509347e-01 | 0.124 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 7.509347e-01 | 0.124 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.509347e-01 | 0.124 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.509347e-01 | 0.124 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.509347e-01 | 0.124 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.510909e-01 | 0.124 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 7.510909e-01 | 0.124 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.510909e-01 | 0.124 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.510909e-01 | 0.124 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.557741e-01 | 0.122 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.572947e-01 | 0.121 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.626256e-01 | 0.118 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.628769e-01 | 0.118 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.629975e-01 | 0.117 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.629975e-01 | 0.117 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.629975e-01 | 0.117 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.655795e-01 | 0.116 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.655795e-01 | 0.116 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 7.655795e-01 | 0.116 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.655795e-01 | 0.116 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.660070e-01 | 0.116 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.663970e-01 | 0.116 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 7.672837e-01 | 0.115 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.698468e-01 | 0.114 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 7.705002e-01 | 0.113 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 7.705002e-01 | 0.113 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 7.705002e-01 | 0.113 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.705002e-01 | 0.113 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 7.705002e-01 | 0.113 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 7.705002e-01 | 0.113 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.705002e-01 | 0.113 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 7.705002e-01 | 0.113 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 7.705002e-01 | 0.113 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 7.720743e-01 | 0.112 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 7.720743e-01 | 0.112 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.720743e-01 | 0.112 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.793290e-01 | 0.108 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.793290e-01 | 0.108 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.793290e-01 | 0.108 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.793290e-01 | 0.108 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 7.793290e-01 | 0.108 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 7.812329e-01 | 0.107 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.856280e-01 | 0.105 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.856280e-01 | 0.105 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.859455e-01 | 0.105 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.869704e-01 | 0.104 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 7.885297e-01 | 0.103 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.885297e-01 | 0.103 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.885297e-01 | 0.103 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 7.885297e-01 | 0.103 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.885297e-01 | 0.103 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.885297e-01 | 0.103 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 7.885297e-01 | 0.103 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.885297e-01 | 0.103 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 7.885297e-01 | 0.103 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 7.885297e-01 | 0.103 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.889576e-01 | 0.103 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.923663e-01 | 0.101 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.929167e-01 | 0.101 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 7.950219e-01 | 0.100 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.961002e-01 | 0.099 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 7.961002e-01 | 0.099 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 7.961002e-01 | 0.099 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 7.967115e-01 | 0.099 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.986934e-01 | 0.098 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.047182e-01 | 0.094 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.047182e-01 | 0.094 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.047182e-01 | 0.094 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.047182e-01 | 0.094 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.051439e-01 | 0.094 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.051439e-01 | 0.094 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.051439e-01 | 0.094 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.051439e-01 | 0.094 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.051439e-01 | 0.094 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.051439e-01 | 0.094 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 8.051439e-01 | 0.094 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.051439e-01 | 0.094 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.051439e-01 | 0.094 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.051439e-01 | 0.094 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.051439e-01 | 0.094 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.051439e-01 | 0.094 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.051439e-01 | 0.094 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.063173e-01 | 0.093 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.070209e-01 | 0.093 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.070209e-01 | 0.093 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.164120e-01 | 0.088 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.168859e-01 | 0.088 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.168859e-01 | 0.088 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.168859e-01 | 0.088 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.168859e-01 | 0.088 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.204537e-01 | 0.086 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.204537e-01 | 0.086 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 8.204537e-01 | 0.086 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.204537e-01 | 0.086 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.204537e-01 | 0.086 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 8.204537e-01 | 0.086 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.204537e-01 | 0.086 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.204537e-01 | 0.086 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.204537e-01 | 0.086 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.204537e-01 | 0.086 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.204537e-01 | 0.086 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.226822e-01 | 0.085 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.248970e-01 | 0.084 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.263190e-01 | 0.083 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.274748e-01 | 0.082 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 8.274748e-01 | 0.082 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.303006e-01 | 0.081 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.344326e-01 | 0.079 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.345614e-01 | 0.079 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.345614e-01 | 0.079 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.345614e-01 | 0.079 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.345614e-01 | 0.079 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.353329e-01 | 0.078 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 8.353329e-01 | 0.078 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.375392e-01 | 0.077 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.378599e-01 | 0.077 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.379335e-01 | 0.077 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.379335e-01 | 0.077 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.379335e-01 | 0.077 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.379335e-01 | 0.077 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.384809e-01 | 0.077 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 8.439407e-01 | 0.074 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.446033e-01 | 0.073 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.475614e-01 | 0.072 | 0 | 0 |
| PKA activation | R-HSA-163615 | 8.475614e-01 | 0.072 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.475614e-01 | 0.072 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 8.475614e-01 | 0.072 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 8.475614e-01 | 0.072 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.475614e-01 | 0.072 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.478147e-01 | 0.072 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.478147e-01 | 0.072 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.478147e-01 | 0.072 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.478147e-01 | 0.072 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.478147e-01 | 0.072 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.478147e-01 | 0.072 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.478147e-01 | 0.072 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.478147e-01 | 0.072 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.500471e-01 | 0.071 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.512564e-01 | 0.070 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.521555e-01 | 0.069 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.539522e-01 | 0.069 | 0 | 0 |
| Translation | R-HSA-72766 | 8.539771e-01 | 0.069 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.571447e-01 | 0.067 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.571447e-01 | 0.067 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.571447e-01 | 0.067 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.572474e-01 | 0.067 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.584593e-01 | 0.066 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.595406e-01 | 0.066 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.595406e-01 | 0.066 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.595406e-01 | 0.066 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 8.595406e-01 | 0.066 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.595406e-01 | 0.066 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 8.595406e-01 | 0.066 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 8.595406e-01 | 0.066 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.595406e-01 | 0.066 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 8.595406e-01 | 0.066 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.599904e-01 | 0.066 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.599904e-01 | 0.066 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.602671e-01 | 0.065 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 8.605760e-01 | 0.065 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.659489e-01 | 0.063 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.659489e-01 | 0.063 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.672644e-01 | 0.062 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.674586e-01 | 0.062 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.705791e-01 | 0.060 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.705791e-01 | 0.060 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.705791e-01 | 0.060 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 8.705791e-01 | 0.060 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.705791e-01 | 0.060 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 8.705791e-01 | 0.060 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.705791e-01 | 0.060 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.705791e-01 | 0.060 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 8.705791e-01 | 0.060 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.742523e-01 | 0.058 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.742523e-01 | 0.058 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.807507e-01 | 0.055 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 8.807507e-01 | 0.055 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 8.807507e-01 | 0.055 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.807507e-01 | 0.055 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 8.807507e-01 | 0.055 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.807507e-01 | 0.055 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 8.807507e-01 | 0.055 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.807507e-01 | 0.055 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.807507e-01 | 0.055 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 8.807507e-01 | 0.055 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 8.807507e-01 | 0.055 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.820793e-01 | 0.054 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.820793e-01 | 0.054 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.835812e-01 | 0.054 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 8.841519e-01 | 0.053 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 8.841519e-01 | 0.053 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 8.841519e-01 | 0.053 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.894534e-01 | 0.051 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.901234e-01 | 0.051 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 8.901234e-01 | 0.051 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 8.901234e-01 | 0.051 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.963975e-01 | 0.047 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.963975e-01 | 0.047 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.963975e-01 | 0.047 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.972598e-01 | 0.047 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.986548e-01 | 0.046 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.987600e-01 | 0.046 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.987600e-01 | 0.046 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 8.987600e-01 | 0.046 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 8.987600e-01 | 0.046 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 8.987600e-01 | 0.046 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 8.987600e-01 | 0.046 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.987600e-01 | 0.046 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.029335e-01 | 0.044 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.067182e-01 | 0.043 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.067182e-01 | 0.043 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.067182e-01 | 0.043 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.067182e-01 | 0.043 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.067182e-01 | 0.043 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.067182e-01 | 0.043 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.090827e-01 | 0.041 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.090827e-01 | 0.041 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.090827e-01 | 0.041 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.090827e-01 | 0.041 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.090827e-01 | 0.041 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.090827e-01 | 0.041 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.090827e-01 | 0.041 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.090827e-01 | 0.041 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.093596e-01 | 0.041 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.105516e-01 | 0.041 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.105516e-01 | 0.041 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.112875e-01 | 0.040 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.112875e-01 | 0.040 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.114759e-01 | 0.040 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.120754e-01 | 0.040 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 9.140512e-01 | 0.039 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.140512e-01 | 0.039 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.140512e-01 | 0.039 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.140512e-01 | 0.039 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.140512e-01 | 0.039 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.140512e-01 | 0.039 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.148655e-01 | 0.039 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.148655e-01 | 0.039 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.148655e-01 | 0.039 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.148655e-01 | 0.039 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 9.151838e-01 | 0.038 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.159645e-01 | 0.038 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.166610e-01 | 0.038 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.202829e-01 | 0.036 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.202829e-01 | 0.036 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.203015e-01 | 0.036 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.208082e-01 | 0.036 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.208082e-01 | 0.036 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.208082e-01 | 0.036 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.208082e-01 | 0.036 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.208082e-01 | 0.036 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.208082e-01 | 0.036 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.208082e-01 | 0.036 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.208082e-01 | 0.036 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.247768e-01 | 0.034 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.254093e-01 | 0.034 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.254093e-01 | 0.034 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.254093e-01 | 0.034 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.259914e-01 | 0.033 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.270344e-01 | 0.033 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.270344e-01 | 0.033 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.270344e-01 | 0.033 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.270344e-01 | 0.033 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.290374e-01 | 0.032 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.293149e-01 | 0.032 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.302071e-01 | 0.031 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.302071e-01 | 0.031 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.302071e-01 | 0.031 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.302071e-01 | 0.031 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.302071e-01 | 0.031 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.316406e-01 | 0.031 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.316406e-01 | 0.031 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.319465e-01 | 0.031 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.325060e-01 | 0.030 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.325060e-01 | 0.030 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.327714e-01 | 0.030 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.327714e-01 | 0.030 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.327714e-01 | 0.030 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.327714e-01 | 0.030 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.327714e-01 | 0.030 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.345085e-01 | 0.029 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.347120e-01 | 0.029 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.347120e-01 | 0.029 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.347120e-01 | 0.029 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.356063e-01 | 0.029 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.380576e-01 | 0.028 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.380576e-01 | 0.028 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.381499e-01 | 0.028 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.389403e-01 | 0.027 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.413269e-01 | 0.026 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.413269e-01 | 0.026 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 9.424385e-01 | 0.026 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 9.424385e-01 | 0.026 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 9.424385e-01 | 0.026 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.429285e-01 | 0.026 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.429285e-01 | 0.026 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.429285e-01 | 0.026 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 9.429285e-01 | 0.026 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.429285e-01 | 0.026 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.429285e-01 | 0.026 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.437467e-01 | 0.025 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.465378e-01 | 0.024 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.466291e-01 | 0.024 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.466291e-01 | 0.024 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.466291e-01 | 0.024 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.474166e-01 | 0.023 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.474166e-01 | 0.023 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.474166e-01 | 0.023 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.474166e-01 | 0.023 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.474166e-01 | 0.023 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 9.474166e-01 | 0.023 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.499875e-01 | 0.022 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.505411e-01 | 0.022 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 9.508017e-01 | 0.022 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.508017e-01 | 0.022 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.515520e-01 | 0.022 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.515520e-01 | 0.022 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.515520e-01 | 0.022 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.515520e-01 | 0.022 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.531659e-01 | 0.021 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.533895e-01 | 0.021 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.553624e-01 | 0.020 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.553624e-01 | 0.020 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.553624e-01 | 0.020 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.559090e-01 | 0.020 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.564548e-01 | 0.019 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.564548e-01 | 0.019 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.564548e-01 | 0.019 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.571933e-01 | 0.019 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.588733e-01 | 0.018 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.588733e-01 | 0.018 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.593265e-01 | 0.018 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.597325e-01 | 0.018 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.600262e-01 | 0.018 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.600262e-01 | 0.018 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.605659e-01 | 0.017 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.606924e-01 | 0.017 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.609496e-01 | 0.017 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.620161e-01 | 0.017 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.621083e-01 | 0.017 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.621083e-01 | 0.017 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.637157e-01 | 0.016 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.645345e-01 | 0.016 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.646212e-01 | 0.016 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.650890e-01 | 0.015 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.650890e-01 | 0.015 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.650890e-01 | 0.015 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.655099e-01 | 0.015 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.655099e-01 | 0.015 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.668919e-01 | 0.015 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.678354e-01 | 0.014 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.678354e-01 | 0.014 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.678354e-01 | 0.014 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.678354e-01 | 0.014 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.678354e-01 | 0.014 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.690981e-01 | 0.014 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.694489e-01 | 0.013 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.702456e-01 | 0.013 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.703659e-01 | 0.013 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.703659e-01 | 0.013 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.703659e-01 | 0.013 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.711623e-01 | 0.013 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.711623e-01 | 0.013 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.712824e-01 | 0.013 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.712824e-01 | 0.013 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.712824e-01 | 0.013 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.713397e-01 | 0.013 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.716505e-01 | 0.012 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.720803e-01 | 0.012 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.723023e-01 | 0.012 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.724924e-01 | 0.012 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.726877e-01 | 0.012 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.726974e-01 | 0.012 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.726974e-01 | 0.012 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.726974e-01 | 0.012 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.726974e-01 | 0.012 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.726974e-01 | 0.012 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.726974e-01 | 0.012 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.730931e-01 | 0.012 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.743407e-01 | 0.011 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.748456e-01 | 0.011 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.748456e-01 | 0.011 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.748456e-01 | 0.011 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.748456e-01 | 0.011 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.748987e-01 | 0.011 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.750195e-01 | 0.011 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.765870e-01 | 0.010 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.766501e-01 | 0.010 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.768250e-01 | 0.010 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.768250e-01 | 0.010 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.768250e-01 | 0.010 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.768250e-01 | 0.010 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.768250e-01 | 0.010 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.786486e-01 | 0.009 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.786486e-01 | 0.009 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.803289e-01 | 0.009 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.803289e-01 | 0.009 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.803289e-01 | 0.009 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.803289e-01 | 0.009 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.803289e-01 | 0.009 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.810180e-01 | 0.008 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.818771e-01 | 0.008 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.818771e-01 | 0.008 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.828019e-01 | 0.008 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.830879e-01 | 0.007 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.833034e-01 | 0.007 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.833034e-01 | 0.007 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.846176e-01 | 0.007 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.858285e-01 | 0.006 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.858285e-01 | 0.006 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.865361e-01 | 0.006 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.869440e-01 | 0.006 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.869440e-01 | 0.006 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.869440e-01 | 0.006 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.873741e-01 | 0.006 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.873741e-01 | 0.006 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.877630e-01 | 0.005 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.895979e-01 | 0.005 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.896276e-01 | 0.005 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.896402e-01 | 0.005 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.897913e-01 | 0.004 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.897913e-01 | 0.004 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.897913e-01 | 0.004 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.899605e-01 | 0.004 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.900096e-01 | 0.004 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.902514e-01 | 0.004 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.906524e-01 | 0.004 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.908653e-01 | 0.004 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.912977e-01 | 0.004 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.912977e-01 | 0.004 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.920180e-01 | 0.003 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.932293e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.938355e-01 | 0.003 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.942294e-01 | 0.003 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.947037e-01 | 0.002 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.948955e-01 | 0.002 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.951090e-01 | 0.002 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.951209e-01 | 0.002 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.953250e-01 | 0.002 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.953936e-01 | 0.002 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.960661e-01 | 0.002 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.961857e-01 | 0.002 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.961857e-01 | 0.002 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.961857e-01 | 0.002 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.961857e-01 | 0.002 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.962475e-01 | 0.002 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.964862e-01 | 0.002 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.967879e-01 | 0.001 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.968331e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.970182e-01 | 0.001 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.974697e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.975819e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.978077e-01 | 0.001 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.978528e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.978528e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.978528e-01 | 0.001 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.979630e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.980221e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.980221e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.983217e-01 | 0.001 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.983217e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.983542e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.983542e-01 | 0.001 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.984348e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.984540e-01 | 0.001 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.984540e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.984540e-01 | 0.001 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.984829e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.986151e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.988715e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.988869e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.991301e-01 | 0.000 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.991301e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.991655e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.991987e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.992090e-01 | 0.000 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.994232e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.995034e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.995369e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.996478e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.996667e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.996921e-01 | 0.000 | 1 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.997059e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.997930e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.998320e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.998392e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.998452e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.998606e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.998871e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.998874e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999247e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999303e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999305e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999318e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999547e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999587e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999730e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.999747e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999777e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999923e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999931e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999953e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999968e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999968e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999972e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999980e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999984e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999990e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999991e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999993e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999995e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999997e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 1 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |